UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of September, 2020

Commission File

Number: 001-04547

 

 

UNILEVER NV

(Translation of registrant’s name into English)

 

 

WEENA 455, 3013 AL, P.O. BOX 760, 3000 DK, ROTTERDAM, THE NETHERLANDS

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports

under cover of Form 20-F or Form 40-F.

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper

as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper

as permitted by Regulation S-T Rule 101(b)(7):  ☐

 

 

 


Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  UNILEVER N.V.
 

/S/ R SOTAMAA

BY   R SOTAMAA
  CHIEF LEGAL OFFICER AND GROUP SECRETARY

Date: 02 September 2020


LOGO

2020 FIRST HALF YEAR RESULTS

Performance highlights (unaudited)

 

Underlying performance

   

GAAP measures

 
           vs 2019                vs 2019  

First Half

           

Underlying sales growth (USG)

       (0.1 )%    Turnover    25.7bn       (1.6 )% 

Underlying operating margin

     19.8     50bps     Operating margin      18.2     60bps  

Underlying earnings per share

   1.35       6.4   Diluted earnings per share    1.25       9.2

Quarterly dividend payable in September 2020

            0.4104 per share  

First half highlights

 

   

Underlying sales declined 0.1% with volume declining 0.3% and price growth of 0.2%

 

   

Turnover decreased 1.6% including a positive impact of 1.1% from acquisitions net of disposals and negative impact of 2.5% from currency

 

   

Underlying operating profit excluding currency increased 3.8%, before a negative impact of 3.2% from currency

 

   

Underlying earnings per share up 6.4%, including a negative impact of 3.7% from currency

 

   

Free cash flow up 1.3 billion to 2.9 billion, reflecting our objective to protect cash during the crisis

 

   

Quarterly shareholder dividend maintained at 0.4104 per share

 

   

Completed acquisitions of Horlicks brand from GSK, enhancing presence in healthy nutrition

 

   

Announced plans to unify the Group legal structure under a single parent company

Alan Jope: Chief Executive Officer statement

“Performance during the first half has shown the true strength of Unilever. We have demonstrated the resilience of the business – in our portfolio, in a continued step-up in operational excellence, and in our financial position - and we have unlocked new levels of agility in responding to unprecedented fluctuations in demand.

We have also taken action to strengthen the strategic future of the company by announcing proposals to unify our dual-headed legal structure, progressing the strategic review of our global tea business and making new commitments to help protect the climate and regenerate nature.

From the start of the Covid-19 crisis, we have been guided by clear priorities in line with our multi-stakeholder business model to protect our people, safeguard supply, respond to new patterns of consumer demand, preserve cash, and support our communities.

Our focus for the rest of 2020 will continue to be volume led competitive growth, absolute profit and cash delivery as this is the best way to maximise shareholder value.

I would like to thank every member of the Unilever team for the outstanding commitment they have shown in the most difficult of circumstances.”

23 July 2020

Underlying sales growth (USG), underlying volume growth (UVG), underlying price growth (UPG), underlying operating profit (UOP), underlying operating margin (UOM), underlying earnings per share (underlying EPS), constant underlying EPS, underlying effective tax rate, free cash flow (FCF) and net debt are non-GAAP measures (see pages 7 to 10)


FIRST HALF OPERATIONAL REVIEW: DIVISIONS

 

     First Half 2020  

(unaudited)

   Turnover      USG     UVG     UPG     Change in
underlying
operating
margin
 
     bn      %     %     %     bps  

Unilever

     25.7        (0.1     (0.3     0.2       50  

Beauty & Personal Care

     10.6        (0.3     0.1       (0.4     50  

Home Care

     5.3        3.2       2.9       0.3       130  

Foods & Refreshment

     9.8        (1.7     (2.5     0.8       (20

Our markets: The spread of Covid-19, combined with the lock-downs and restrictions that have been implemented in many countries, has led to significant changes in the operating environment in our markets. Consumer demand patterns have been impacted by channel closures, more time spent in the home and the critical importance of hygiene.

China was the first of our markets to be impacted by Covid-19, entering lock-down in January. China slowed significantly during the lock-down period, with some recovery after April as the economy opened back up. In most other major markets, sales patterns in January and February were normal and Covid-19 impacted from March onwards. In North America and parts of Europe there was a positive impact from household stocking in March. Consumption patterns then normalised in the second quarter with heightened levels of demand for hygiene and in home food products. Market growth in India had already been slowing prior to the spread of Covid-19 and the market was further impacted by the introduction of the strict national lock-down at the end of March. This national lock-down continued until early June, when it was followed by further regional lock-downs. Latin America was impacted by Covid-19 later than other major markets, with the effects primarily in the second quarter, exacerbating already challenging conditions in the region.

Unilever overall performance: Underlying sales declined 0.1% with volumes declining 0.3% and price growth of 0.2%. Developed markets grew 2.4% whilst emerging markets declined 1.9%.

The impact of Covid-19 on our business in the first half varied widely across our channels and categories. Channel closures as a result of lock-downs in our markets negatively impacted our food service, out of home ice cream and Prestige businesses. Food service declined by nearly 40% and out of home ice cream declined by nearly 30%. Shoppers moved from offline to online channels, driving e-commerce growth of 49%.

As people spent more time in their homes, we saw growth in home consumption of foods, ice cream and tea. It also meant that consumers had fewer personal care occasions from going to work or socialising, and we saw a decline in our personal care business, except for hygiene products. The effectiveness of good hygiene practices against the spread of Covid-19 increased demand for our hand and home hygiene products, which each grew double digits. Consumers eating and cleaning more at home, and focusing more on hand hygiene, led to underlying sales growth in North America of 9.5% in the second quarter, despite a negative impact of 3.7% from food solutions and Prestige channel closures.

The lock-downs introduced in our markets during the first half varied in severity, with some having a more significant impact on the supply and availability of goods, particularly those in India and China. China entered lock-down in January and declined mid-teens during the first quarter. The market re-opened from April, and China returned to mid-single digit growth in the second quarter. Growth in India was impacted by the lock-down implemented from March.

Turnover decreased 1.6%. There was a positive impact of 1.1% from acquisitions net of disposals and a negative impact of 2.5% from currency.

Underlying operating profit was 5.1 billion, an increase of 3.8% excluding a negative impact from currency of 3.2%. Underlying operating margin improved by 50bps. As consumer habits and the status of lock-downs have been changing during this period, we have been quick to adapt and reallocate our brand and marketing investment week by week. In response to lock-downs in our markets, we reduced spend in some channels and geographies while maintaining investment in growth opportunities. This, combined with a deflationary environment in media rates, led to a reduction in brand and marketing investment by 100bps during the period. In the second half of the year, we expect to see higher brand and marketing investment, as lock-downs ease and we support brand campaigns and product innovations tailored to the new environment. Gross margin reduced by 30bps driven by costs to adapt and run our supply chain in response to Covid-19, ensuring the safety and continuity of our operations, as well as an adverse mix effect. Overheads increased by 20bps, including an adverse currency mix.

USG, UVG, UPG, UOP, UOM, underlying EPS, constant underlying EPS, underlying effective tax rate, FCF and net debt are non-GAAP measures (see pages 7 to 10)

 

2


We delivered free cash flow of 2.9 billion, an increase of 1.3 billion. The increase was driven by favourable working capital movements, reduced capital expenditure and lower cash tax paid, primarily a result of higher tax on disposals in the prior year relating to the disposal of the spreads business.

Covid-19 response and support measures: Unilever has put in place a wide-ranging set of measures to support global and national efforts to tackle the Covid-19 pandemic.

In our own operations, strict protocols for hygiene and physical distancing are in place for Unilever’s sourcing units and distribution centres. Unilever’s office-based employees have been working from home since March, with some limited reopening of office workplaces in selected countries, where stringent requirements have been met.

We are supporting global efforts to tackle Covid-19, contributing 100 million through donations of soap, sanitiser, bleach and food. We are also working in partnership with others, including a programme to reach up to a billion people globally with the UK Department for International Development to urgently tackle the spread of the disease through raising hygiene awareness and changing behaviour. We have also made available up to 500 million of cash flow relief for our most vulnerable small and medium sized suppliers, though so far the levels of uptake have been low.

Unilever’s financial strength remains robust and we have not sought Covid-19 related financial support from any governments.

Strategic review of tea: In January Unilever announced a strategic review of its global tea business, which includes leading brands such as Lipton, Brooke Bond and PG Tips.

This review has assessed a full range of options. We will retain the tea businesses in India and Indonesia and the partnership interests in the ready-to-drink tea joint ventures.

The balance of Unilever’s tea brands and geographies and all tea estates have an exciting future, and this potential can best be achieved as a separate entity. A process will now begin to implement the separation, which is expected to conclude by the end of 2021.

The tea business that will be separated generated revenues of 2 billion in 2019.

Recent acquisitions: In the first half of the year, we completed the acquisitions of the health food drinks portfolio of GlaxoSmithKline in India, Bangladesh and 20 other predominantly Asian markets. Acquiring the iconic brands Horlicks and Boost is in line with Unilever’s strategy to enhance its presence in healthy nutrition.

Beauty & Personal Care

Beauty & Personal Care underlying sales declined 0.3%, with volume growth of 0.1% and negative pricing of 0.4%.

Skin cleansing saw mid-teens volume-led growth, as we quickly responded to the critical need for hand hygiene to prevent the spread of Covid-19. We rolled out our Lifebuoy hygiene brand to over 50 markets and increased our hand sanitiser capacity by around 600 times across several brands. This helped contribute to double digit growth for Suave. Lock-downs in our markets and reduced personal care occasions amidst restricted living, led to lower demand for skin care, deodorants and hair care, which each saw volume and price decline. The division’s largest brand Dove remained resilient, with mid-single digit growth. Our Prestige portfolio was impacted by health and beauty channel closures in many markets. Consumer oral care demand remained robust. However, the category saw negative volumes related to disruption caused by lock-downs in key markets. Turnover decreased by 1.0% including a 1.3% contribution from acquisitions and an adverse 2.0% currency related impact.

Underlying operating margin in Beauty & Personal Care increased by 50bps. Gross margin was lower, with negative pricing and an impact from mix, and overheads increased. This was offset by a reduction in brand and marketing investment through lock-down periods.

USG, UVG, UPG, UOP, UOM, underlying EPS, constant underlying EPS, underlying effective tax rate, FCF and net debt are non-GAAP measures (see pages 7 to 10)

 

3


Home Care

Home Care underlying sales grew 3.2%, with 2.9% from volume and positive pricing of 0.3%.

We saw increased consumer demand for household cleaning products, such as Cif surface cleaners, and our home and hygiene brands delivered high-teens underlying sales growth. Working with environmental health experts, Domestos educated consumers about targeted cleaning of high-touch surfaces in the home to help prevent the spread of Covid-19 and saw strong double digit growth. Strict lock-downs in Asia impacted fabric solutions, which declined overall. However future formats such as capsules and liquids continued to grow. Clean and green brand Seventh Generation saw strong double digit, volume-led growth. Fabric sensations declined low-single digit, driven by Brazil and China. Turnover declined by 1.5% including 0.3% contribution from acquisitions and 4.8% unfavourable impact from currency.

Underlying operating margin in Home Care increased by 130bps, driven by gross margin improvements from savings delivery and lower commodity costs.

Foods & Refreshment

Foods & Refreshment underlying sales declined 1.7%, with volumes down 2.5% and positive pricing of 0.8%.

Lock-downs in most markets led to the closure of out of home channels. This, together with reduced tourism, led to a reduction in out of home ice cream sales of nearly 30%. Similarly, food service sales were down around 40% as hotels, restaurants, cafes and bars closed. At the same time, we saw double digit growth in our retail foods business with Knorr and Hellmann’s performing strongly. Sales of ice cream for consumption in home increased by 15% in the first half and by 26% in the second quarter, significantly offsetting the declines in out of home channels. Magnum and Ben and Jerry’s continued to grow strongly. Turnover declined 2.2% including 1.3% contribution from acquisitions net of disposals and 1.7% unfavourable impact from currency.

Underlying operating margin in Foods & Refreshment declined by 20bps. Gross margin fell, driven by mix, volume deleverage from out of home channel closures and costs related to Covid-19. This was partially offset by a reduction in brand and marketing investment.

USG, UVG, UPG, UOP, UOM, underlying EPS, constant underlying EPS, underlying effective tax rate, FCF and net debt are non-GAAP measures (see pages 7 to 10)

 

4


FIRST HALF OPERATIONAL REVIEW: GEOGRAPHICAL AREA

 

     First Half 2020  

(unaudited)

   Turnover      USG     UVG     UPG     Change in
underlying
operating
margin
 
     bn      %     %     %     bps  

Unilever

     25.7        (0.1     (0.3     0.2       50  

Asia/AMET/RUB

     11.8        (2.7     (2.9     0.2       (40

The Americas

     8.2        5.0       4.1       0.9       220  

Europe

     5.7        (1.8     (1.0     (0.8     (30

 

     First Half 2020  

(unaudited)

   Turnover      USG     UVG     UPG  
     bn      %     %     %  

Developed markets

     10.9        2.4       3.0       (0.6

Emerging markets

     14.8        (1.9     (2.6     0.7  

North America

     5.1        7.3       7.7       (0.4

Latin America

     3.1        1.9       (0.8     2.8  

Asia/AMET/RUB

Underlying sales declined 2.7% with volume decline of 2.9% and positive pricing of 0.2%. Volumes were impacted by lock-downs of varying severity imposed across the region. China, the first market to enter lock-down, starting from January and easing in April, declined in the first quarter. Following the relaxation of restrictions, China returned to mid-single digit growth in the second quarter, although food service remained challenging. India and the Philippines declined, as strict lock-downs were imposed from March, disrupting the flow of goods and negatively impacting consumption of discretionary personal care categories as consumers stayed at home more. Thailand was negatively impacted by reduced tourism. Regional lock-downs were imposed in Indonesia as Covid-19 spread, however, growth was positive over the half year. Turnover declined by 3.2% including 1.2% increase from acquisitions net of disposals and unfavourable contribution of 1.7% from currency.

Underlying operating margin was down 40bps with a reduction in gross margin and higher overheads, driven by investment in our connected stores programme in South Asia, which digitises the retail value chain, and partially offset by lower brand and marketing investment.

The Americas

Underlying sales growth in North America was 7.3% with 7.7% from volume and a decline of 0.4% from price. This growth includes negative impact of around 3% from our food service and prestige businesses which were impacted by channel closures. The decline in these businesses was offset by increased consumption of in home foods and ice cream as well as hygiene products; consumption which was sustained throughout the second quarter. Our supply chain responded quickly to increase capacity for products experiencing a surge in demand.

Latin America grew 1.9% with volumes down 0.8% and positive pricing of 2.8%. The impact of Covid-19 on the region was concentrated in the second half of the period. Mexico saw negative volumes and a sequential decline in the second quarter, more than offsetting growth in the first quarter. Brazil grew low-single digit overall, as a second quarter decline only partially offset growth in the first quarter. Volumes grew in Argentina throughout the first half, driven by in-home foods consumption, against a backdrop of prolonged strict lock-down measures.

Turnover increased by 1.1% including 1.4% positive impact of acquisitions net of disposals and a negative impact of 5.1% from currency.

Underlying operating margin was up 220bps, with lower brand and marketing investment as well as an improvement in overheads, which was driven by savings programmes in Latin America and volume leverage in North America.

Europe

Underlying sales declined 1.8% with negative volumes of 1.0% and price down 0.8%. Negative volumes in Europe were a result of significant declines in out of home ice cream and food service, as well as reduced demand for personal care products. The most severely impacted countries were Italy and Spain, where increased demand for in home eating and hygiene products only partially offset these negative impacts. The UK grew mid-single digit and Germany low-single digit however, as increased demand for in home eating and hygiene products more than offset declines in the negatively impacted categories. Turnover declined by 1.9% including 0.2% increase from acquisitions net of disposals and an adverse impact of 0.3% from currency.

Underlying operating margin was down 30bps, with a reduction in gross margin due to adverse mix and supply chain costs related to Covid-19 as well as higher overheads, driven by volume deleverage and other one-off items, which were partially offset by lower brand and marketing investment.

USG, UVG, UPG, UOP, UOM, underlying EPS, constant underlying EPS, underlying effective tax rate, FCF and net debt are non-GAAP measures (see pages 7 to 10)

 

5


ADDITIONAL COMMENTARY ON THE FINANCIAL STATEMENTS – FIRST HALF 2020

Finance costs and tax

Net finance costs decreased by 102 million to 249 million in the first half of 2020. The decrease was driven by interest on tax credits in Brazil and India and exchange rate losses on cash balances in Zimbabwe in the prior year. Cost of borrowings decreased due to lower hedging costs, partly offset by lower income on cash as interest rates declined. The interest rate on average net debt decreased to 2.0% from 2.8% in the prior year.

The underlying effective tax rate for H1 2020 was 22.6% compared with 26.2% in H1 2019. The decrease was primarily driven by favourable tax settlements which were agreed during the period, a reduction in the India tax rate and replacement of Indian distribution tax with a dividend withholding tax. The effective tax rate for H1 2020 was 22.3% compared with 26.8% in H1 2019.

Joint ventures, associates and other income from non-current investments

Net profit from joint ventures and associates was 89 million, compared to 85 million in the prior year. Income from other non-current investments was zero versus 2 million in 2019.

Earnings per share

Constant underlying earnings per share increased by 10.1%. Underlying earnings per share on a current currency basis increased by 6.4% to 1.35, following a negative currency impact of 3.7%. The improvement was driven by reduced tax and net finance costs, as well as higher operating profit. These movements were slightly reduced by an increase in profit attributable to minority interests following the completion of the merger between Unilever’s listed subsidiary in India and GlaxoSmithKline’s Consumer Healthcare Limited.

Diluted earnings per share increased by 9.2% to 1.25 led by the improvement in underlying EPS.

Free cash flow

Free cash flow in the first half of 2020 was 2.9 billion, up from 1.5 billion in the first half of 2019. The improvement was primarily led by favourable working capital movement as we enhanced our focus on receivables management, as well as reduced capital expenditure following a review of all spend in light of the Covid-19 crisis. In addition, cash tax paid was lower as the prior year included payments relating to the disposal of the spreads business and tax settlements.

Net debt

Closing net debt decreased to 22.8 billion compared with 23.1 billion at 31 December 2019. Increases to net debt due to dividends paid and acquisitions were offset by the free cash flow delivery.

Pensions

Pension liabilities net of assets increased to 0.4 billion at the end of June 2020 versus 0.2 billion as at 31 December 2019. Higher liabilities resulting from falling discount rates were partially offset by positive investment returns on pension assets.

Finance and liquidity

On 25 March 2020 Unilever announced the issuance of 1,000 million 1.25% fixed rate notes due March 2025 and 1,000 million 1.75% fixed rate notes due March 2030.

In April 2020, 300 million 0.0% fixed rate notes matured and were repaid. In May 2020, $800 million 1.8% fixed rate notes and $150 million 5.15% fixed rate notes matured and were repaid.

On 31 December 2019 Unilever had undrawn revolving 364-day bilateral credit facilities in aggregate of $7,865 million with a 364-day term out. As part of the regular annual process, the facilities were renewed in the first half of 2020 (undrawn balance at 30 June 2020 was $7,965 million). The intention is that these facilities will again be renewed in 2021.

 

USG, UVG, UPG, UOP, UOM, underlying EPS, constant underlying EPS, underlying effective tax rate, FCF and net debt are non-GAAP measures (see pages 7 to 10)

 

6


COMPETITION INVESTIGATIONS

As previously disclosed, Unilever is involved in a number of ongoing investigations and cases by national competition authorities, including those within Italy, Greece and South Africa. These proceedings and investigations are at various stages and concern a variety of product markets. Where appropriate, provisions are made and contingent liabilities disclosed in relation to such matters.

Ongoing compliance with competition laws is of key importance to Unilever. It is Unilever’s policy to co-operate fully with competition authorities whenever questions or issues arise. In addition the Group continues to reinforce and enhance its internal competition law training and compliance programme on an ongoing basis.

NON-GAAP MEASURES

Certain discussions and analyses set out in this announcement include measures which are not defined by generally accepted accounting principles (GAAP) such as IFRS. We believe this information, along with comparable GAAP measurements, is useful to investors because it provides a basis for measuring our operating performance, ability to retire debt and invest in new business opportunities. Our management uses these financial measures, along with the most directly comparable GAAP financial measures, in evaluating our operating performance and value creation. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP. Wherever appropriate and practical, we provide reconciliations to relevant GAAP measures.

Unilever uses ‘constant rate’, and ‘underlying’ measures primarily for internal performance analysis and targeting purposes. We present certain items, percentages and movements, using constant exchange rates, which exclude the impact of fluctuations in foreign currency exchange rates. We calculate constant currency values by translating both the current and the prior period local currency amounts using the prior year average exchange rates into euro, except for the local currency of entities that operate in hyperinflationary economies. These currencies are translated into euros using the prior year closing exchange rate before the application of IAS 29. The table below shows exchange rate movements in our key markets.

 

     First half
average rate in
     First half
average rate in
 
     2020      2019  
               

Brazilian Real (1 = BRL)

     5.323        4.282  

Chinese Yuan (1 = CNY)

     7.743        7.659  

Indian Rupee (1 = INR)

     81.535        79.149  

Indonesia Rupiah (1 = IDR)

     16055        16046  

Philippine Peso (1 = PHP)

     55.823        59.010  

UK Pound Sterling (1 = GBP)

     0.873        0.873  

US Dollar (1 = US $)

     1.102        1.130  

Underlying sales growth (USG)

Underlying sales growth (USG) refers to the increase in turnover for the period, excluding any change in turnover resulting from acquisitions, disposals, changes in currency and price growth in excess of 26% in hyperinflationary economies. Inflation of 26% per year compounded over three years is one of the key indicators within IAS 29 to assess whether an economy is deemed to be hyperinflationary. We believe this measure provides valuable additional information on the underlying sales performance of the business and is a key measure used internally. The impact of acquisitions and disposals is excluded from USG for a period of 12 calendar months from the applicable closing date. Turnover from acquired brands that are launched in countries where they were not previously sold is included in USG as such turnover is more attributable to our existing sales and distribution network than the acquisition itself. The reconciliation of changes in the GAAP measure turnover to USG is provided in notes 3 and 4.

Underlying price growth (UPG)

Underlying price growth (UPG) is part of USG and means, for the applicable period, the increase in turnover attributable to changes in prices during the period. UPG therefore excludes the impact to USG due to (i) the volume of products sold; and (ii) the composition of products sold during the period. In determining changes in price we exclude the impact of price growth in excess of 26% per year in hyperinflationary economies as explained in USG above. The measures and the related turnover GAAP measure are set out in notes 3 and 4.

Underlying volume growth (UVG)

Underlying volume growth (UVG) is part of USG and means, for the applicable period, the increase in turnover in such period calculated as the sum of (i) the increase in turnover attributable to the volume of products sold; and (ii) the increase in turnover attributable to the composition of products sold during such period. UVG therefore excludes any impact on USG due to changes in prices. The measures and the related turnover GAAP measure are set out in notes 3 and 4.

 

7


NON-GAAP MEASURES (continued)

 

Non-underlying items

Several non-GAAP measures are adjusted to exclude items defined as non-underlying due to their nature and/or frequency of occurrence.

 

   

Non-underlying items within operating profit are: gains or losses on business disposals, acquisition and disposal related costs, restructuring costs, impairments and one-off items within operating profit.

 

   

Non-underlying items not in operating profit but within net profit are: net monetary gain/(loss) arising from hyperinflationary economies and significant and unusual items in net finance cost, share of profit/(loss) of joint ventures and associates and taxation.

 

   

Non-underlying items are: both non-underlying items within operating profit and those non-underlying items not in operating profit but within net profit.

Underlying operating profit (UOP) and underlying operating margin (UOM)

Underlying operating profit and underlying operating margin mean operating profit and operating margin before the impact of non-underlying items within operating profit. Underlying operating profit represents our measure of segment profit or loss as it is the primary measure used for making decisions about allocating resources and assessing performance of the segments. The reconciliation of operating profit to underlying operating profit is as follows:

 

€ million

 

   First Half  

(unaudited)

   2020      2019  

Operating profit

     4,672        4,589  

Non-underlying items within operating profit (see note 2)

     412        465  
  

 

 

    

 

 

 

Underlying operating profit

     5,084        5,054  
  

 

 

    

 

 

 

Turnover

     25,714        26,126  

Operating margin (%)

     18.2        17.6  

Underlying operating margin (%)

     19.8        19.3  

Underlying effective tax rate

The underlying effective tax rate is calculated by dividing taxation excluding the tax impact of non-underlying items by profit before tax excluding the impact of non-underlying items and share of net profit/(loss) of joint ventures and associates. This measure reflects the underlying tax rate in relation to profit before tax excluding non-underlying items before tax and share of net profit/(loss) of joint ventures and associates. Tax impact on non-underlying items within operating profit is the sum of the tax on each non-underlying item, based on the applicable country tax rates and tax treatment. This is shown in the following table:

 

€ million

 

   First Half  

(unaudited)

   2020     2019  

Taxation

     991       1,145  

Tax impact:

    

Non-underlying items within operating profit(a)

     109       89  

Non-underlying items not in operating profit but within net profit(a)

     (7     –    
  

 

 

   

 

 

 

Taxation before tax impact of non-underlying items

     1,093       1,234  
  

 

 

   

 

 

 

Profit before taxation

     4,533       4,354  

Non-underlying items within operating profit before tax(a)

     412       465  

Non-underlying items not in operating profit but within net profit before tax(b)

     (21     (29

Share of net profit /(loss) of joint ventures and associates

     (89     (85
  

 

 

   

 

 

 

Profit before tax excluding non-underlying items before tax and share of net profit/(loss) of joint ventures and associates

     4,835       4,705  
  

 

 

   

 

 

 

Underlying effective tax rate

     22.6     26.2

 

(a)

Refer to note 2 for further details on these items.

(b)

2019 amount excludes 3 million gain on disposal of spreads business by the joint venture in Portugal which is included in the share of net profit/(loss) of joint ventures and associates line. Including the 3 million, total non-underlying items not in operating profit but within net profit before tax is 32 million. Refer to note 2 for further details.

 

8


NON-GAAP MEASURES (continued)

 

Underlying earnings per share (EPS)

Underlying earnings per share (underlying EPS) is calculated as underlying profit attributable to shareholders’ equity divided by the diluted combined average number of share units. In calculating underlying profit attributable to shareholders’ equity, net profit attributable to shareholders’ equity is adjusted to eliminate the post-tax impact of non-underlying items. This measure reflects the underlying earnings for each share unit of the Group. Refer to note 6 for reconciliation of net profit attributable to shareholders’ equity to underlying profit attributable to shareholders equity.

Constant underlying EPS

Constant underlying earnings per share (constant underlying EPS) is calculated as underlying profit attributable to shareholders’ equity at constant exchange rates and excluding the impact of both translational hedges and price growth in excess of 26% per year in hyperinflationary economies divided by the diluted average number of ordinary share units. This measure reflects the underlying earnings for each share unit of the Group in constant exchange rates.

The reconciliation of underlying profit attributable to shareholders’ equity to constant underlying earnings attributable to shareholders’ equity and the calculation of constant underlying EPS is as follows:

 

€ million    First Half  

(unaudited)

   2020      2019  

Underlying profit attributable to shareholders’ equity (see note 6)

     3,559        3,342  

Impact of translation from current to constant exchange rates and translational hedges

     127        (1

Impact of price growth in excess of 26% per year in hyperinflationary economies

     (6      –    
  

 

 

    

 

 

 

Constant underlying earnings attributable to shareholders’ equity

     3,680        3,341  
  

 

 

    

 

 

 

Diluted combined average number of share units (millions of units)

     2,627.2        2,625.6  
  

 

 

    

 

 

 

Constant underlying EPS ()

     1.40        1.27  
  

 

 

    

 

 

 

Net debt

Net debt is a measure that provides valuable additional information on the summary presentation of the Group’s net financial liabilities and is a measure in common use elsewhere. Net debt is defined as the excess of total financial liabilities, excluding trade payables and other current liabilities, over cash, cash equivalents and other current financial assets, excluding trade and other current receivables, and non-current financial asset derivatives that relate to financial liabilities.

The reconciliation of total financial liabilities to net debt is as follows:

 

€ million

 

(unaudited)

   As at
30 June
2020
     As at
31 December
2019
     As at
30 June
2019
 

Total financial liabilities

     (28,805      (28,257      (28,985

Current financial liabilities

     (4,792      (4,691      (5,616

Non-current financial liabilities

     (24,013      (23,566      (23,369

Cash and cash equivalents as per balance sheet

     4,855        4,185        3,911  

Cash and cash equivalents as per cash flow statement

     4,722        4,116        3,789  

Add bank overdrafts deducted therein

     133        69        122  

Other current financial assets

     1,100        907        913  

Non-current financial assets derivatives that relate to financial liabilities

     96        114        –    
  

 

 

    

 

 

    

 

 

 

Net debt

     (22,754      (23,051      (24,161
  

 

 

    

 

 

    

 

 

 

 

9


NON-GAAP MEASURES (continued)

 

Free cash flow (FCF)

Within the Unilever Group, free cash flow (FCF) is defined as cash flow from operating activities, less income taxes paid, net capital expenditure and net interest payments. It does not represent residual cash flows entirely available for discretionary purposes; for example, the repayment of principal amounts borrowed is not deducted from FCF. FCF reflects an additional way of viewing our liquidity that we believe is useful to investors because it represents cash flows that could be used for distribution of dividends, repayment of debt or to fund our strategic initiatives, including acquisitions, if any.

The reconciliation of net profit to FCF is as follows:

 

€ million    First Half  

(unaudited)

   2020      2019  

Net profit

     3,542        3,209  

Taxation

     991        1,145  

Share of net profit of joint ventures/associates and other income from non-current investments

     (89      (87

Net monetary gain arising from hyperinflationary economies

     (21      (29

Net finance costs

     249        351  
  

 

 

    

 

 

 

Operating profit

     4,672        4,589  
  

 

 

    

 

 

 

Depreciation, amortisation and impairment

     987        965  

Changes in working capital

     (1,215      (1,888

Pensions and similar obligations less payments

     (79      (94

Provisions less payments

     (66      47  

Elimination of (profits)/losses on disposals

     45        (36

Non-cash charge for share-based compensation

     74        95  

Other adjustments

     9        23  
  

 

 

    

 

 

 

Cash flow from operating activities

     4,427        3,701  
  

 

 

    

 

 

 

Income tax paid

     (899      (1,309

Net capital expenditure

     (422      (558

Net interest paid

     (256      (291
  

 

 

    

 

 

 

Free cash flow

     2,850        1,543  
  

 

 

    

 

 

 

Total net cash flow (used in)/from investing activities

     (581      (716

Total net cash flow (used in)/from financing activities

     (2,088      (856

GUARANTOR INFORMATION

On 13 August 2020, Unilever N.V. (NV) and Unilever Capital Corporation (UCC) filed a US Shelf registration, the debt securities issued from the Shelf registration are unconditionally and fully guaranteed, jointly and severally by NV, Unilever PLC (PLC) and Unilever United States, Inc. (UNUS). UCC and UNUS are each indirectly 100% owned by the Unilever parent entities (as defined below). US$11.6 billion of Notes previously issued were outstanding at 30 June 2020 (30 June 2019: US$11.0 billion; 30 June 2018: US$11.0 billion) with coupons ranging from 1.375% to 5.900%. These Notes are repayable between 30 July 2020 and 15 November 2032.

These debt securities can be issued either by UCC or NV and are senior, unsecured and unsubordinated. Where debt is issued by UCC, it is fully and unconditionally guaranteed, on a joint and several basis, by NV, PLC and UNUS. Where debt is issued by NV, it is fully and unconditionally guaranteed, on a joint and several basis, by PLC and UNUS. To date, all outstanding debt issued from previous shelf registration statements on Form F-3 has been issued by UCC.

In March 2020, the SEC amended Rule 3-10 of Regulation S-X and created Rule 13-01 to simplify disclosure requirements related to certain registered securities, which we have adopted effective immediately. As noted above UCC and UNUS are 100% subsidiaries of Unilever N.V. and Unilever PLC (collectively known as the Unilever parent entities) and are consolidated in the financial statements of the Unilever Group. In addition, there are no material assets in the guarantor entities apart from intercompany investments and balances. Therefore, as allowed under Rule 13-01, we have excluded the summarised information for each issuer and guarantor.    

The guarantees provide that, in case of the failure of the relevant issuer to punctually make payment of any principal, premium or interest, each guarantor agrees to ensure such payment is made when due whether at the stated maturity or by declaration of acceleration, call for redemption or otherwise. The guarantees also provide that the Trustee shall be paid any and all amounts due to it under the guarantee upon which the debt securities are endorsed.

 

10


PRINCIPAL RISK FACTORS

On pages 35 to 39 of our 2019 Annual Report and Accounts on Form 20-F we set out our assessment of the principal risk issues that would face the business under the headings: brand preference; portfolio management; climate change; plastic packaging; customer; talent; supply chain; safe and high quality products; systems and information; business transformation; economic and political instability; treasury and tax; ethical; and legal and regulatory. The Covid-19 pandemic has increased the potential impact of certain of these risks and the longer term impacts will depend on a range of factors including the duration and scope of the pandemic, the geographies impacted, the impact of the pandemic on economic activity and the nature and severity of measures adopted by governments, including restrictions in business operations, travel, mandates to avoid large gathering and orders to self-quarantine or shelter in place. The Covid-19 pandemic may have significant negative impacts in the medium and long term on the business.

Changes in consumer behaviour as a result of government imposed lock downs and the need for people to self-quarantine, shelter in place or observe social distancing for an indeterminate period of time has reduced demand for certain products, particularly those which rely on out of home consumption. Demand for certain personal care products has also been affected as a result of reduced usage by consumers in stay at home settings. The severity of government-imposed lock downs and the period for which they continue in different countries will have an impact on consumer demand in those countries. In the longer term a deterioration in the financial position of consumers as a result of Covid-19 pandemic may also impact demand for products. In addition, disruptions as a result of Covid-19 in manufacturing, supply and distribution arrangements, including those of third parties may adversely impact operations.

CAUTIONARY STATEMENT

This announcement may contain forward-looking statements, including ‘forward-looking statements’ within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as ‘will’, ‘aim’, ‘expects’, ‘anticipates’, ‘intends’, ‘looks’, ‘believes’, ‘vision’, or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the ‘Group’). They are not historical facts, nor are they guarantees of future performance.

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever’s global brands not meeting consumer preferences; Unilever’s ability to innovate and remain competitive; Unilever’s investment choices in its portfolio management; the effect of climate change on Unilever’s business; Unilever’s ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current Covid-19 pandemic. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Further details of potential risks and uncertainties affecting the Group are described in the Group’s filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2019 and the Unilever Annual Report and Accounts 2019.

ENQUIRIES

 

Media: Media Relations Team

  

Investors: Investor Relations Team

UK

or

NL

or

  

+44 78 2527 3767

+44 77 7999 9683

+31 10 217 4844

+31 62 375 8385

  

lucila.zambrano@unilever.com

JSibun@tulchangroup.com

els-de.bruin@unilever.com

marlous-den.bieman@unilever.com

  

+44 20 7822 6830

  

investor.relations@unilever.com

There will be a web cast of the results presentation available at:

www.unilever.com/investor-relations/results-and-presentations/latest-results

 

11


CONSOLIDATED INCOME STATEMENT

(unaudited)

 

€ million

   First Half  
     2020     2019     Increase/
(Decrease)
 
  Current
rates
    Constant
rates
 

Turnover

     25,714       26,126       (1.6 )%      1.2

Operating profit

     4,672       4,589       1.8     5.1

Which includes non-underlying items credits/(charges) of

     (412     (465    

Net finance costs

     (249     (351    

Finance income

     139       86      

Finance costs

     (378     (420    

Pensions and similar obligations

     (10     (17    

Non-underlying item net monetary gain/(loss) arising from hyperinflationary economies

     21       29      

Share of net profit/(loss) of joint ventures and associates

     89       85      

Which includes non-underlying item credits/(charges) of

     –         3      

Other income/(loss) from non-current investments and associates

     –         2      

Profit before taxation

     4,533       4,354       4.1     8.0

Taxation

     (991     (1,145    

Which includes tax impact of non-underlying items of

     102       89      

Net profit

     3,542       3,209       10.4     14.7

Attributable to:

        

Non-controlling interests

     258       203      

Shareholders’ equity

     3,284       3,006       9.3     13.8
  

 

 

   

 

 

   

 

 

   

 

 

 

Combined earnings per share

        

Basic earnings per share (euros)

     1.25       1.15       9.2     13.7

Diluted earnings per share (euros)

     1.25       1.14       9.2     13.7

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

(unaudited)

 

€ million

   First Half  
     2020     2019  

Net profit

     3,542       3,209  

Other comprehensive income

    

Items that will not be reclassified to profit or loss, net of tax:

    

Gains/(losses) on equity instruments measured at fair value through other comprehensive income

     20       16  

Remeasurements of defined benefit pension plans

     (201     267  

Items that may be reclassified subsequently to profit or loss, net of tax:

    

Gains/(losses) on cash flow hedges

     43       83  

Currency retranslation gains/(losses)(a)

     (1,481     64  
  

 

 

   

 

 

 

Total comprehensive income

     1,923       3,639  
  

 

 

   

 

 

 

Attributable to:

    

Non-controlling interests

     177       216  

Shareholders’ equity

     1,746       3,423  

 

(a)

2020 currency retranslation losses resulted from the weakening of currencies against the euro in our foreign operations, primarily in Brazil, Mexico, India, Korea and Russia.

 

12


CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

(unaudited)

 

€ million

   Called up
share
capital
    Share
premium
account
    Other
reserves
    Retained
profit
    Total     Non-
controlling
interest
    Total
equity
 

First half - 2020

              
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

1 January 2020

     420       134       (5,574     18,212       13,192       694       13,886  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Profit or loss for the period

     –         –         –         3,284       3,284       258       3,542  

Other comprehensive income, net of tax:

              

Gains/(losses) on:

              

Equity instruments

     –         –         16       –         16       4       20  

Cash flow hedges

     –         –         46       –         46       (3     43  

Remeasurements of defined benefit pension plans

     –         –         –         (200     (200     (1     (201

Currency retranslation gains/(losses)

     –         –         (1,387     (13     (1,400     (81     (1,481
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total comprehensive income

     –         –         (1,325     3,071       1,746       177       1,923  

Dividends on ordinary capital

     –         –         –         (2,149     (2,149     –         (2,149

Other movements in treasury shares(a)

     –         –         190       (126     64       –         64  

Share-based payment credit(b)

     –         –         –         74       74       –         74  

Dividends paid to non-controlling interests

     –         –         –         –         –         (210     (210

Currency retranslation gains/(losses) net of tax

     –         (7     –         –         (7     –         (7

Hedging gain/(loss) transferred to non-financial assets

     –         –         –         –         –         1       1  

Net gain arising from Horlicks acquisition(c)

     –         –         –         2,930       2,930       1,918       4,848  

Other movements in equity(d)

     –         –         –         (211     (211     5       (206
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

30 June 2020

     420       127       (6,709     21,801       15,639       2,585       18,224  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

First half - 2019

              

1 January 2019 as previously reported

     464       129       (15,286     26,265       11,572       720       12,292  

IFRS 16 Restatement

     –         –         68       (243     (175     –         (175

Impact of adopting IFRIC 23

     –         –         –         (38     (38     –         (38
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

1 January 2019 after restatement

     464       129       (15,218     25,984       11,359       720       12,079  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Profit or loss for the period

     –         –         –         3,006       3,006       203       3,209  

Other comprehensive income, net of tax:

              

Gains/(losses) on:

              

Equity instruments

     –         –         14       –         14       2       16  

Cash flow hedges

     –         –         83       –         83       –         83  

Remeasurements of defined benefit pension plans

     –         –         –         266       266       1       267  

Currency retranslation gains/(losses)

     –         –         50       4       54       10       64  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total comprehensive income

     –         –         147       3,276       3,423       216       3,639  

Dividends on ordinary capital

     –         –         –         (2,079     (2,079     –         (2,079

Cancellation of treasury shares(e)

     (30     –         6,599       (6,569     –         –         –    

Other movements in treasury shares(a)

     –         –         31       (180     (149     –         (149

Share-based payment credit(b)

     –         –         –         95       95       –         95  

Dividends paid to non-controlling interests

     –         –         –         –         –         (237     (237

Currency retranslation gains/(losses) net of tax

     –         –         –         –         –         –         –    

Hedging gain/(loss) transferred to non-financial assets

     –         –         35       –         35       –         35  

Other movements in equity

     –         –         –         26       26       (13     13  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

30 June 2019

     434       129       (8,406     20,553       12,710       686       13,396  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a)

Includes purchases and sales of treasury stock, and transfer from treasury stock to retained profit of share-settled schemes arising from prior years and differences between exercise and grant price of share options.

(b)

The share-based payment credit relates to the non-cash charge recorded against operating profit in respect of the fair value of share options and awards granted to employees.

(c)

Consideration for the Main Horlicks Acquisition included the issuance of shares in a group subsidiary, Hindustan Unilever Limited, which resulted in a net gain being recognised within equity. See note 7 for further details.

(d)

2020 includes 163 million paid for purchase of the non-controlling interest in Unilever Malaysia.

(e)

During the first half of 2019 170,000,000 Unilever N.V. ordinary shares and 18,660,634 Unilever PLC ordinary shares were cancelled. The amount paid to repurchase these shares was initially recognised in other reserves and is transferred to retained profit on cancellation.

 

13


CONSOLIDATED BALANCE SHEET

(unaudited)

 

€ million

   As at
30 June
2020
     As at
31 December
2019
     As at
30 June
2019
 

Non-current assets

        

Goodwill

     19,675        18,067        17,697  

Intangible assets

     16,049        12,962        12,547  

Property, plant and equipment

     11,374        12,062        12,067  

Pension asset for funded schemes in surplus

     2,296        2,422        2,053  

Deferred tax assets

     1,325        1,336        1,376  

Financial assets

     815        874        705  

Other non-current assets

     896        653        495  
  

 

 

    

 

 

    

 

 

 
     52,430        48,376        46,940  
  

 

 

    

 

 

    

 

 

 

Current assets

        

Inventories

     4,646        4,164        4,387  

Trade and other current receivables

     6,955        6,695        8,079  

Current tax assets

     336        397        265  

Cash and cash equivalents

     4,855        4,185        3,911  

Other financial assets

     1,100        907        913  

Assets held for sale

     56        82        34  
  

 

 

    

 

 

    

 

 

 
     17,948        16,430        17,589  
  

 

 

    

 

 

    

 

 

 

Total assets

     70,378        64,806        64,529  
  

 

 

    

 

 

    

 

 

 

Current liabilities

        

Financial liabilities

     4,792        4,691        5,616  

Trade payables and other current liabilities

     14,602        14,768        14,391  

Current tax liabilities

     1,051        898        1,072  

Provisions

     530        620        665  

Liabilities held for sale

     1        1        1  
  

 

 

    

 

 

    

 

 

 
     20,976        20,978        21,745  
  

 

 

    

 

 

    

 

 

 

Non-current liabilities

        

Financial liabilities

     24,013        23,566        23,369  

Non-current tax liabilities

     289        182        187  

Pensions and post-retirement healthcare liabilities:

        

Funded schemes in deficit

     1,275        1,157        1,176  

Unfunded schemes

     1,426        1,461        1,417  

Provisions

     642        664        637  

Deferred tax liabilities

     3,276        2,573        2,272  

Other non-current liabilities

     257        339        330  
  

 

 

    

 

 

    

 

 

 
     31,178        29,942        29,388  
  

 

 

    

 

 

    

 

 

 

Total liabilities

     52,154        50,920        51,133  
  

 

 

    

 

 

    

 

 

 

Equity

        

Shareholders’ equity

     15,639        13,192        12,710  

Non-controlling interests

     2,585        694        686  
  

 

 

    

 

 

    

 

 

 

Total equity

     18,224        13,886        13,396  
  

 

 

    

 

 

    

 

 

 

Total liabilities and equity

     70,378        64,806        64,529  
  

 

 

    

 

 

    

 

 

 

 

14


CONSOLIDATED CASH FLOW STATEMENT

(unaudited)

 

€ million

   First Half  
     2020     2019  

Net profit

     3,542       3,209  

Taxation

     991       1,145  

Share of net (profit)/loss of joint ventures/associates and other (income)/loss from non-current investments and associates

     (89     (87

Net monetary (gain)/loss arising from hyperinflationary economies

     (21     (29

Net finance costs

     249       351  
  

 

 

   

 

 

 

Operating profit

     4,672       4,589  
  

 

 

   

 

 

 

Depreciation, amortisation and impairment

     987       965  

Changes in working capital

     (1,215     (1,888

Pensions and similar obligations less payments

     (79     (94

Provisions less payments

     (66     47  

Elimination of (profits)/losses on disposals

     45       (36

Non-cash charge for share-based compensation

     74       95  

Other adjustments

     9       23  
  

 

 

   

 

 

 

Cash flow from operating activities

     4,427       3,701  
  

 

 

   

 

 

 

Income tax paid

     (899     (1,309
  

 

 

   

 

 

 

Net cash flow from operating activities

     3,528       2,392  
  

 

 

   

 

 

 

Interest received

     80       78  

Net capital expenditure

     (422     (558

Other acquisitions and disposals

     (623     (470

Other investing activities

     384       234  
  

 

 

   

 

 

 

Net cash flow (used in)/from investing activities

     (581     (716
  

 

 

   

 

 

 

Dividends paid on ordinary share capital

     (2,120     (2,080

Interest paid

     (336     (369

Change in financial liabilities

     602       1,937  

Other movements on treasury shares

     –         (205

Other financing activities

     (234     (139
  

 

 

   

 

 

 

Net cash flow (used in)/from financing activities

     (2,088     (856
  

 

 

   

 

 

 

Net increase/(decrease) in cash and cash equivalents

     859       820  
  

 

 

   

 

 

 

Cash and cash equivalents at the beginning of the period

     4,116       3,090  

Effect of foreign exchange rate changes

     (253     (121
  

 

 

   

 

 

 

Cash and cash equivalents at the end of the period

     4,722       3,789  
  

 

 

   

 

 

 

 

15


NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(unaudited)

1 ACCOUNTING INFORMATION AND POLICIES

The accounting policies and methods of computation are in compliance with IAS 34 ‘Interim Financial Reporting’ as issued by the International Accounting Standard Board (IASB) and as adopted by the EU; and except as set out below are consistent with the year ended 31 December 2019. The condensed interim financial statements are based on International Financial Reporting Standards (IFRS) as adopted by the EU and IFRS as issued by the IASB.

Management have produced forecasts which have been modelled for different plausible downside scenarios as a result of the Covid-19 pandemic. These scenarios confirm the Group is able to generate profits and cash in the year ended 31 December 2020 and beyond. As a result, the Directors have a reasonable expectation that the Group has adequate resources to meet its obligations as they fall due for a period of at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the half year financial statements.

The condensed interim financial statements are shown at current exchange rates, while percentage year-on-year changes are shown at both current and constant exchange rates to facilitate comparison. The consolidated income statement on page 12, the consolidated statement of comprehensive income on page 12, the consolidated statement of changes in equity on page 13 and the consolidated cash flow statement on page 15 are translated at exchange rates current in each period. The consolidated balance sheet on page 14 is translated at period-end rates of exchange.

The condensed interim financial statements attached do not constitute the full financial statements within the meaning of section 434 of the UK Companies Act 2006. The comparative figures for the financial year ended 31 December 2019 are not Unilever PLC’s statutory accounts for that financial year. Those accounts of Unilever for the year ended 31 December 2019 have been reported on by the Group’s auditor and delivered to the Registrar of Companies. The report of the auditor on these accounts was (i) unqualified, (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498 (2) or (3) of the UK Companies Act 2006.

Recent accounting developments

Interest Rate Benchmark Reform - Amendments to IFRS 9, IAS 39 and IFRS 7

The Group has adopted the amendments that modify specific hedge accounting requirements to allow entities to continue to forecast future cash flows assuming that the interest rate benchmark will continue despite ongoing reviews of interest rate benchmark reform. As a result, there is no requirement for an entity to discontinue hedge relationships or to reassess the economic relationships between hedged items and hedging instruments as a result of the uncertainties of the interest rate benchmark reform. The Group does not have material derivatives that refer to an interest rate benchmark so these amendments do not have a material impact on Unilever.

 

16


NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(unaudited)

 

2 SIGNIFICANT ITEMS WITHIN THE INCOME STATEMENT

Non-underlying items

These include non-underlying items within operating profit and non-underlying items not in operating profit but with net profit:

 

   

Non-underlying items within operating profit are gains or losses on business disposals, acquisition and disposal related costs, restructuring costs, impairment and one-off items within operating profit.

 

   

Non-underlying items not in operating profit but with net profit are net monetary gain/(loss) arising from hyperinflationary economies and significant and unusual items in net finance cost, share of profit/(loss) of joint ventures and associates and taxation.

Restructuring costs are charges associated with activities planned by management that significantly change either the scope of the business or the manner in which it is conducted.

 

€ million

   First Half  
     2020      2019  

Acquisition and disposal-related credit/(costs)

     (27      (77

Gain/(loss) on disposal of group companies(a)

     6        66  

Restructuring costs

     (391      (454

Impairment

     –          –    

One-off items

     –          –    
  

 

 

    

 

 

 

Non-underlying items within operating profit before tax

     (412      (465

Tax on non-underlying items within operating profit

     109        89  
  

 

 

    

 

 

 

Non-underlying items within operating profit after tax

     (303      (376
  

 

 

    

 

 

 

Share of gain on disposal of Spreads business in Portugal JV

     –          3  

Net monetary gain arising from hyperinflationary economies

     21        29  
  

 

 

    

 

 

 

Non-underlying items not in operating profit but within net profit before tax

     21        32  

Tax impact of non-underlying items not in operating profit but within net profit:

     

Hyperinflation adjustment for Argentina deferred tax

     (7      –    
  

 

 

    

 

 

 

Non-underlying items not in operating profit but within net profit after tax

     14        32  
  

 

 

    

 

 

 

Non-underlying items after tax(b)

     (289      (344
  

 

 

    

 

 

 

Attributable to:

     

Non-controlling interests

     (14      (8

Shareholders’ equity

     (275      (336

 

(a)

2019 includes a gain of 60 million relating to disposal of Alsa baking and dessert business.

(b)

Non-underlying items after tax is calculated as non-underlying items within operating profit after tax plus non-underlying items not in operating profit but within net profit after tax.

 

17


NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(unaudited)

 

3 SEGMENT INFORMATION - DIVISIONS

 

First Half

   Beauty &
Personal
Care
     Home
Care
     Foods &
Refreshment
     Total  

Turnover ( million)

           

2019

     10,721        5,410        9,995        26,126  

2020

     10,610        5,328        9,776        25,714  

Change (%)

     (1.0      (1.5      (2.2      (1.6

Impact of:

           

Acquisitions (%)

     1.3        0.3        1.7        1.2  

Disposals (%)

     –          –          (0.4      (0.2

Currency-related items (%), of which:

     (2.0      (4.8      (1.7      (2.5

Exchange rates changes (%)

     (2.2      (5.1      (2.0      (2.7

Extreme price growth in hyperinflationary markets* (%)

     0.3        0.3        0.3        0.3  

Underlying sales growth (%)

     (0.3      3.2        (1.7      (0.1
  

 

 

    

 

 

    

 

 

    

 

 

 

Price* (%)

     (0.4      0.3        0.8        0.2  

Volume (%)

     0.1        2.9        (2.5      (0.3
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating profit ( million)

           

2019

     2,322        652        1,615        4,589  

2020

     2,403        744        1,525        4,672  

Underlying operating profit ( million)

           

2019

     2,469        756        1,829        5,054  

2020

     2,495        817        1,772        5,084  

Operating margin (%)

           

2019

     21.7        12.1        16.2        17.6  

2020

     22.6        14.0        15.6        18.2  

Underlying operating margin (%)

           

2019

     23.0        14.0        18.3        19.3  

2020

     23.5        15.3        18.1        19.8  

 

*

Underlying price growth in excess of 26% per year in hyperinflationary economies has been excluded when calculating the price growth in the tables above, and an equal and opposite amount is shown as extreme price growth in hyperinflationary markets.

Turnover growth is made up of distinct individual growth components namely underlying sales, currency impact, acquisitions and disposals. Turnover growth is arrived at by multiplying these individual components on a compounded basis as there is a currency impact on each of the other components. Accordingly, turnover growth is more than just the sum of the individual components.

Underlying operating profit represents our measure of segment profit or loss as it is the primary measure used for the purpose of making decisions about allocating resources and assessing performance of segments. Underlying operating margin is calculated as underlying operating profit divided by turnover.

 

18


NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(unaudited)

 

4 SEGMENT INFORMATION - GEOGRAPHICAL AREA

 

First Half

   Asia /
AMET /
RUB
     The
Americas
     Europe      Total  

Turnover ( million)

           

2019

     12,195        8,141        5,790        26,126  

2020

     11,807        8,227        5,680        25,714  

Change (%)

     (3.2      1.1        (1.9      (1.6

Impact of:

           

Acquisitions (%)

     1.4        1.5        0.5        1.2  

Disposals (%)

     (0.2      (0.1      (0.3      (0.2

Currency-related items (%), of which:

     (1.7      (5.1      (0.3      (2.5

Exchange rates changes (%)

     (1.8      (5.8      (0.3      (2.7

Extreme price growth in hyperinflationary markets* (%)

     0.1        0.7        –          0.3  

Underlying sales growth (%)

     (2.7      5.0        (1.8      (0.1
  

 

 

    

 

 

    

 

 

    

 

 

 

Price* (%)

     0.2        0.9        (0.8      0.2  

Volume (%)

     (2.9      4.1        (1.0      (0.3
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating profit ( million)

           

2019

     2,339        1,270        980        4,589  

2020

     2,265        1,532        875        4,672  

Underlying operating profit ( million)

           

2019

     2,526        1,425        1,103        5,054  

2020

     2,394        1,622        1,068        5,084  

Operating margin (%)

           

2019

     19.2        15.6        16.9        17.6  

2020

     19.2        18.6        15.4        18.2  

Underlying operating margin (%)

           

2019

     20.7        17.5        19.1        19.3  

2020

     20.3        19.7        18.8        19.8  

 

*

Underlying price growth in excess of 26% per year in hyperinflationary economies has been excluded when calculating the price growth in the tables above, and an equal and opposite amount is shown as extreme price growth in hyperinflationary markets.

 

19


NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(unaudited)

 

5 TAXATION

The effective tax rate for the first half was 22.3% compared to 26.8% in 2019, a decrease primarily driven by favourable tax settlements agreed during the period, a reduction in the India tax rate and replacement of Indian distribution tax with a dividend withholding tax. The tax rate is calculated by dividing the tax charge by pre-tax profit excluding the contribution of joint ventures and associates.

Tax effects of components of other comprehensive income were as follows:

 

     First Half 2020     First Half 2019  

million

   Before
tax
    Tax
(charge)/
credit
    After
tax
    Before
tax
     Tax
(charge)/
credit
    After
tax
 

Gains/(losses) on

             

Equity instruments at fair value through other comprehensive income

     19       1       20       16        –         16  

Cash flow hedges

     71       (28     43       89        (6     83  

Remeasurements of defined benefit pension plans

     (242     41       (201     274        (7     267  

Currency retranslation gains/(losses)

     (1,516     35       (1,481     68        (4     64  
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Other comprehensive income

     (1,668     49       (1,619     447        (17     430  
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

6 COMBINED EARNINGS PER SHARE

 

     2020      2019  

Combined EPS – Basic

     

Net profit attributable to shareholders’ equity ( million)

     3,284        3,006  

Average number of combined share units (millions of units)

     2,619.0        2,616.5  

Combined EPS – basic ()

     1.25        1.15  

Combined EPS – Diluted

     

Net profit attributable to shareholders’ equity ( million)

     3,284        3,006  

Adjusted average number of combined share units (millions of units)

     2,627.2        2,625.6  

Combined EPS – diluted ()

     1.25        1.14  

Underlying EPS

     

Net profit attributable to shareholder’s equity ( million)

     3,284        3,006  

Post tax impact of non-underlying items attributable to shareholders’ equity (see note 2)

     275        336  
  

 

 

    

 

 

 

Underlying profit attributable to shareholders’ equity ( million)

     3,559        3,342  

Adjusted average number of combined share units (millions of units)

     2,627.2        2,625.6  

Underlying EPS – diluted ()

     1.35        1.27  

In calculating underlying earnings per share, net profit attributable to shareholders’ equity is adjusted to eliminate the post-tax impact of non-underlying items.

During the period the following movements in shares have taken place:

 

     Millions  

Number of shares at 31 December 2019 (net of treasury shares)

     2,616.8  

Net movement in shares under incentive schemes

     4.5  
  

 

 

 

Number of shares at 30 June 2020

     2,621.3  
  

 

 

 

 

20


NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(unaudited)

 

7 ACQUISITIONS AND DISPOSALS

Total consideration for acquisitions completed in the first half of 2020 is 5,526 million (acquisitions completed in the first half of 2019: 654 million). A material acquisition in the first half of 2020 was the purchase of the health food drinks portfolio of GlaxoSmithKline plc in India and 20 other predominantly Asian markets (“the Main Horlicks Acquisition”). There were no other significant acquisitions completed in the first half of 2020.

Horlicks Acquisitions

The Main Horlicks Acquisition was composed of the following related transactions on 1 April 2020:

 

 

Hindustan Unilever Limited (HUL), a subsidiary of the Group, obtained control of the business of GlaxoSmithKline Consumer Healthcare Limited (GSKCH) via an all equity merger under which 4.39 shares of HUL were allotted for every share of GSKCH;

 

 

HUL purchased the Horlicks intellectual property rights, being mainly legal rights to the Horlicks brand (the ‘HFD IP’) for India and Unilever N.V. and Unilever PLC purchased the HFD IP outside of India and Bangladesh; and

 

 

Unilever Foods (Malaysia) Sdn Bhd and Unilever Asia Pacific Limited (Singapore) purchased the Horlicks commercial operations of GSK in 20 other predominantly Asian markets (“Local Distribution Assets”).

The Bangladesh Horlicks Acquisition is separate to the Main Horlicks Acquisition and completed on 30 June 2020. Unilever Overseas Holding B.V. purchased 82% of GSK Bangladesh Limited and Unilever PLC purchased the HFD IP in Bangladesh. The following disclosures relate only to the Main Horlicks Acquisition.

Main Horlicks Acquisition

The purpose of the acquisition was to add the Horlicks and Boost brands in certain geographical markets to Unilever’s portfolio to increase presence in healthy nutrition and in high-growth emerging markets.

Effect on consolidated income statement

The acquisition contributed 142 million to Group turnover and 39 million to Group operating profit since the acquisition date. If the acquisition had taken place at the beginning of the year, Group turnover would have been 25,856 million and Group operating profit would have been 4,711 million.

Effect on consolidated balance sheet

The 5,294 million consideration comprised of 449 million in cash and 4,845 million in shares of Hindustan Unilever Limited valued based on the share price of HUL on the completion date and the exchange rate on the same date (83.05 INR/).

The fair value of the net assets acquired are set out in the table below. The amounts are provisional and subject to change.

 

      million  

Intangible assets

     3,345  

Other non-current assets

     249  

Deferred tax (net)

     (746

Other financial assets

     463  

Trade and other receivables

     74  

Other current assets

     94  

Non-current liabilities

     (159

Current liabilities

     (122
  

 

 

 

Net assets acquired

     3,198  

Goodwill

     2,096  
  

 

 

 

Total consideration

     5,294  
  

 

 

 

Net cash outflow arising on acquisition:

  

Cash consideration

     (449

Less cash and cash equivalents acquired

     36  
  

 

 

 

Total outflow in the consolidated statement of cash flows

     (413
  

 

 

 

 

21


NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(unaudited)

 

7 ACQUISITIONS AND DISPOSALS (continued)

 

Goodwill represents the future value which the Group believes it will obtain through operational synergies, such as the overlapping distribution network, tax benefits on goodwill and working capital improvements and leveraging from the competencies and capabilities of the Horlicks brand presence and recognition to generate stronger market power. We expect around 1.3 billion of the goodwill to be deductible for tax purposes. While we believe there is legal basis to claim the Horlicks goodwill as tax deductible, we expect challenges to this from the Indian tax authorities. Since the acquisition date, foreign exchange has decreased this goodwill in euros by 44 million.

The gross contractual value of trade and other receivables as at the dates of acquisition amounted to 74 million which is expected to be fully recoverable.

Within the acquired net assets, contingent liabilities amounting to 123 million in respect of ongoing litigation against GlaxoSmithKline Consumer Healthcare Limited have been recognised based on management’s estimate of the values of exposures and their assessment of the probability of the related claims being settled by the Group. The contingent liabilities mainly relate to direct and indirect tax disputes with the Indian tax authorities. There are several matters being disputed and in each case we believe that the likelihood that the Indian tax authorities will ultimately prevail is no higher than moderate, however we expect that most of these disputes will not be resolved for several years. Contingent assets of 73 million are also recognised, measured on the same basis, for the Group’s right to future indemnification by GlaxoSmithKline Pte Limited and Horlicks Limited in relation to certain claims.

Acquisition-related costs of 29 million have been recorded within non-underlying items in the consolidated income statement for the half year period to 30 June 2020 (full year 2019: 12 million). Total costs relating to the issuance of shares amounting to 5 million have been recognised against equity by Hindustan Unilever Limited.

Impact of dilution of Group interest in Hindustan Unilever Limited

The acquisition of GSKCH by HUL was settled through the issue of (184.6 million) new shares of Hindustan Unilever Limited and so resulted in dilution of Unilever’s interest in Hindustan Unilever Limited from 67.2% to 61.9%. The table below shows the impact of the decrease in shareholding on the equity attributable to shareholders of the Group.

 

      million  

67.2% share of HUL’s net assets acquired before acquisition of GSKCH

     718  

61.9% share of HUL’s net assets acquired after acquisition of GSKCH

     661  
  

 

 

 

Loss recognised in equity due to dilution

     (57

Gain arising from proportionate share of GSKCH’s net assets acquired

     3,001  
  

 

 

 

Net gain arising from the Main Horlicks acquisition recognized in equity

     2,944  
  

 

 

 

 

22


NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(unaudited)

 

8 FINANCIAL INSTRUMENTS

The Group’s Treasury function aims to protect the Group’s financial investments, while maximising returns. The fair value of financial assets is the same as the carrying amount for 2020 and 2019. The Group’s cash resources and other financial assets are shown below.

 

€ million

  30 June 2020     31 December 2019     30 June 2019  
    Current     Non-current     Total     Current     Non-current     Total     Current     Non-current     Total  

Cash and cash equivalents

                 

Cash at bank and in hand

    2,672       –         2,672       2,457       –         2,457       2,157       –         2,157  

Short-term deposits with maturity of three months or less

    2,176       –         2,176       1,693       –         1,693       1,568       –         1,568  

Other cash equivalents

    7       –         7       35       –         35       186       –         186  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    4,855       –         4,855       4,185             4,185       3,911             3,911  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other financial assets

                 

Financial assets at amortised cost(a)

    774       129       903       578       220       798       239       260       499  

Financial assets at fair value through other comprehensive income(b)

    –         304       304       –         266       266       110       217       327  

Financial assets at fair value through profit or loss:

                 

Derivatives that relate to financial liabilities

    69       96       165       20       114       134       411       –         411  

Other(c)

    257       286       543       309       274       583       153       228       381  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    1,100       815       1,915       907       874       1,781       913       705       1,618  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total financial assets(d)

    5,955       815       6,770       5,092       874       5,966       4,824       705       5,529  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a)

Current financial assets at amortised cost include short term deposits with banks with maturities longer than three months and loans to joint venture entities. Non-current financial assets at amortised cost include judicial deposit of 94 million (December 2019: 136 million) and investment in bonds of nil million (December 2019: 56 million).

(b)

Included within non-current financial assets at fair value through other comprehensive income are equity investments of 284 million (December 2019: 244 million).

(c)

Included within current financial assets at fair value through profit or loss are highly liquid debt mutual funds. Included within non-current financial assets at fair value through profit or loss are assets in a trust to fund benefit obligations in the US and investments in a number of companies and financial institutions in North America, North Asia, South Asia and Europe.

(d)

Financial assets exclude trade and other current receivables.

The Group is exposed to the risks of changes in fair value of its financial assets and liabilities. The following tables summarise the fair values and carrying amounts of financial instruments and the fair value calculations by category.

 

     Fair value     Carrying amount  

€ million

   As at
30 June
2020
    As at
31 December
2019
    As at
30 June
2019
    As at
30 June
2020
    As at
31 December
2019
    As at
30 June
2019
 

Financial assets

            

Cash and cash equivalents

     4,855       4,185       3,911       4,855       4,185       3,911  

Financial assets at amortised cost

     903       798       499       903       798       499  

Financial assets at fair value through other comprehensive income

     304       266       327       304       266       327  

Financial assets at fair value through profit and loss:

            

Derivatives

     165       134       411       165       134       411  

Other

     543       583       381       543       583       381  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     6,770       5,966       5,529       6,770       5,966       5,529  

Financial liabilities

            

Bank loans and overdrafts

     (851     (853     (1,044     (851     (853     (1,041

Bonds and other loans

     (28,206     (26,525     (26,787     (25,837     (25,032     (25,390

Lease liabilities

     (1,849     (1,919     (1,967     (1,849     (1,919     (1,967

Derivatives

     (76     (270     (464     (76     (270     (464

Other financial liabilities

     (192     (183     (123     (192     (183     (123
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     (31,174     (29,750     (30,385     (28,805     (28,257     (28,985
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

23


NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(unaudited)

 

8 FINANCIAL INSTRUMENTS (continued)

 

     Level 1      Level 2     Level 3     Level 1      Level 2     Level 3     Level 1      Level 2     Level 3  

€ million

   As at 30 June 2020     As at 31 December 2019     As at 30 June 2019  

Assets at fair value

                     

Financial assets at fair value through other comprehensive income

     5        4       295       7        4       255       116        4       207  

Financial assets at fair value through profit or loss:

                     

Derivatives(a)

     –          268       –         –          208       –         –          448       –    

Other

     260        –         283       311        –         272       155        –         226  

Liabilities at fair value

                     

Derivatives(b)

     –          (187     –         –          (326     –         –          (530     –    

Contingent Consideration

     –          –         (155     –          –         (154     –          –         (156

 

(a)

Includes 103 million (December 2019: 74 million, June 2019: 37 million) derivatives, reported within trade receivables, that hedge trading activities.

(b)

Includes (111) million (December 2019:  (56) million, June 2019: (66) million) derivatives, reported within trade payables, that hedge trading activities.

There were no significant changes in classification of fair value of financial assets and financial liabilities since 31 December 2019. There were also no significant movements between the fair value hierarchy classifications since 31 December 2019.

The fair value of trade receivables and payables is considered to be equal to the carrying amount of these items due to their short-term nature.

Calculation of fair values

The fair values of the financial assets and liabilities are defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Methods and assumptions used to estimate the fair values are consistent with those used in the year ended 31 December 2019.

9 DIVIDENDS

The Boards have determined to pay a quarterly interim dividend for Q1 2020 and Q2 2020 at the following rates which are equivalent in value between the two companies at the rate of exchange applied under the terms of the Equalisation Agreement:

 

     Q1 2020      Q2 2020  

Per Unilever N.V. ordinary share

   0.4104      0.4104  

Per Unilever PLC ordinary share

   £ 0.3614      £ 0.3698  

Per Unilever N.V. New York share

   US$ 0.4445      US$ 0.4694  

Per Unilever PLC American Depositary Receipt

   US$  0.4445      US$  0.4694  

The quarterly interim dividends have been determined in euros and converted into equivalent sterling and US dollar amounts using exchange rates issued by WM/Reuters on 21 April 2020 and 21 July 2020 for Q1 and Q2 respectively.

US dollar cheques for Q2 interim dividend will be mailed on 9 September 2020 to holders of record at the close of business on 7 August 2020. In the case of the NV New York shares, Netherlands withholding tax will be deducted.

The quarterly dividend calendar for the remainder of 2020 will be as follows:

 

    

Announcement
Date

  

Ex-Dividend
Date

  

Record Date

  

Payment Date

Q2 2020 Dividend

   23 July 2020    6 August 2020    7 August 2020    9 September 2020

Q3 2020 Dividend

   22 October 2020    5 November 2020    6 November 2020    2 December 2020

10 EVENTS AFTER THE BALANCE SHEET DATE

There were no material post balance sheet events other than those mentioned elsewhere in this report.

 

24

v3.20.2
Cover
6 Months Ended
Jun. 30, 2020
Cover [Abstract]  
Document Type 6-K
Amendment Flag false
Document Period End Date Jun. 30, 2020
Entity Registrant Name UNILEVER N V
Entity Central Index Key 0000110390
Current Fiscal Year End Date --12-31
Document Fiscal Year Focus 2020
Document Fiscal Period Focus Q2
v3.20.2
Consolidated Income Statement - EUR (€)
€ in Millions
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Profit or loss [abstract]    
Turnover € 25,714 € 26,126
Operating profit 4,672 4,589
Which includes non-underlying item credits/(charges) of (412) (465)
Net finance costs (249) (351)
Finance income 139 86
Finance costs (378) (420)
Pensions and similar obligations (10) (17)
Non-underlying item net monetary gain/(loss) arising from hyperinflationary economies 21 29
Share of net profit/(loss) of joint ventures and associates 89 85
Which includes non-underlying item credits/(charges) of   3
Other income/(loss) from non-current investments and associates   2
Profit before taxation 4,533 4,354
Taxation (991) (1,145)
Which includes tax impact of non-underlying items of 102 89
Net profit 3,542 3,209
Attributable to:    
Non-controlling interests 258 203
Shareholders' equity € 3,284 € 3,006
Combined earnings per share    
Basic earnings per share (€) € 1.25 € 1.15
Diluted earnings per share (€) € 1.25 € 1.14
v3.20.2
Consolidated Statement of Comprehensive Income - EUR (€)
€ in Millions
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Statement of comprehensive income [abstract]    
Net profit € 3,542 € 3,209
Items that will not be reclassified to profit or loss, net of tax:    
Gains/(losses) on equity instruments measured at fair value through other comprehensive income 20 16
Remeasurements of defined benefit pension plans (201) 267
Items that may be reclassified subsequently to profit or loss, net of tax:    
Gains/(losses) on cash flow hedges 43 83
Currency retranslation gains/(losses) [1] (1,481) 64
Total comprehensive income 1,923 3,639
Attributable to:    
Non-controlling interests 177 216
Shareholders' equity € 1,746 € 3,423
[1] 2020 currency retranslation losses resulted from the weakening of currencies against the euro in our foreign operations, primarily in Brazil, Mexico, India, Korea and Russia.
v3.20.2
Consolidated Statement of Changes in Equity - EUR (€)
€ in Millions
Total
Called up share capital [member]
Share Premium Account [member]
Other reserves [member]
Retained profit [member]
Equity Attributable to Owners of Parent [member]
Non-controlling Interests [member]
Beginning balance (Previously Reported [member]) at Dec. 31, 2018 € 12,292 € 464 € 129 € (15,286) € 26,265 € 11,572 € 720
Beginning balance (IFRS 16 Restatement [member]) at Dec. 31, 2018 (175)     68 (243) (175)  
Impact of adopting IFRIC 23 at Dec. 31, 2018 (38)       (38) (38)  
Beginning balance after restatement at Dec. 31, 2018 12,079 464 129 (15,218) 25,984 11,359 720
Profit or loss for the period 3,209       3,006 3,006 203
Other comprehensive income, net of tax:              
Gains/(losses) on equity instruments 16     14   14 2
Gain/(losses) on Cash flow hedges 83     83   83  
Remeasurements of defined benefit pension plans 267       266 266 1
Currency retranslation gains/(losses) 64 [1]     50 4 54 10
Total comprehensive income 3,639     147 3,276 3,423 216
Dividends on ordinary capital (2,079)       (2,079) (2,079)  
Cancellation of treasury shares [2]   (30)   6,599 (6,569)    
Other movements in treasury shares (149)     31 (180) (149)  
Share-based payment credit [3] 95       95 95  
Dividends paid to non-controlling interests (237)           (237)
Currency retranslation gains/(losses) net of tax           0  
Hedging gain/(loss) transferred to non-financial assets 35     35   35  
Other movements in equity [4] 13       26 26 (13)
Ending balance at Jun. 30, 2019 13,396 434 129 (8,406) 20,553 12,710 686
Beginning balance at Dec. 31, 2019 13,886 420 134 (5,574) 18,212 13,192 694
Profit or loss for the period 3,542       3,284 3,284 258
Other comprehensive income, net of tax:              
Gains/(losses) on equity instruments 20     16   16 4
Gain/(losses) on Cash flow hedges 43     46   46 (3)
Remeasurements of defined benefit pension plans (201)       (200) (200) (1)
Currency retranslation gains/(losses) (1,481) [1]     (1,387) (13) (1,400) (81)
Total comprehensive income 1,923     (1,325) 3,071 1,746 177
Dividends on ordinary capital (2,149)       (2,149) (2,149)  
Other movements in treasury shares [5] 64     190 (126) 64  
Share-based payment credit [3] 74       74 74  
Dividends paid to non-controlling interests (210)           (210)
Currency retranslation gains/(losses) net of tax (7)   (7)     (7)  
Hedging gain/(loss) transferred to non-financial assets 1           1
Net gain arising from Horlicks acquisition [6] 4,848       2,930 2,930 1,918
Other movements in equity [4] (206)       (211) (211) 5
Ending balance at Jun. 30, 2020 € 18,224 € 420 € 127 € (6,709) € 21,801 € 15,639 € 2,585
[1] 2020 currency retranslation losses resulted from the weakening of currencies against the euro in our foreign operations, primarily in Brazil, Mexico, India, Korea and Russia.
[2] During the first half of 2019 170,000,000 Unilever N.V. ordinary shares and 18,660,634 Unilever PLC ordinary shares were cancelled. The amount paid to repurchase these shares was initially recognised in other reserves and is transferred to retained profit on cancellation.
[3] The share-based payment credit relates to the non-cash charge recorded against operating profit in respect of the fair value of share options and awards granted to employees.
[4] 2020 includes €163 million paid for purchase of the non-controlling interest in Unilever Malaysia.
[5] Includes purchases and sales of treasury stock, and transfer from treasury stock to retained profit of share-settled schemes arising from prior years and differences between exercise and grant price of share options.
[6] Consideration for the Main Horlicks Acquisition included the issuance of shares in a group subsidiary, Hindustan Unilever Limited, which resulted in a net gain being recognised within equity. See note 7 for further details.
v3.20.2
Consolidated Statement of Changes in Equity (Parenthetical) - EUR (€)
€ in Millions
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Unilever Malaysia [Member]    
Payments for purchase of noncontrolling interest € 163  
NV Member    
Number of shares cancelled   170,000,000
PLC Member    
Number of shares cancelled   18,660,634
v3.20.2
Consolidated Balance Sheet - EUR (€)
€ in Millions
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2019
Non-current assets      
Goodwill € 19,675 € 18,067 € 17,697
Intangible assets 16,049 12,962 12,547
Property, plant and equipment 11,374 12,062 12,067
Pension asset for funded schemes in surplus 2,296 2,422 2,053
Deferred tax assets 1,325 1,336 1,376
Financial assets [1] 815 874 705
Other non-current assets 896 653 495
Total non-current assets 52,430 48,376 46,940
Current assets      
Inventories 4,646 4,164 4,387
Trade and other current receivables 6,955 6,695 8,079
Current tax assets 336 397 265
Cash and cash equivalents 4,855 4,185 3,911
Other financial assets 1,100 907 913
Assets held for sale 56 82 34
Current assets 17,948 16,430 17,589
Total assets 70,378 64,806 64,529
Current liabilities      
Financial liabilities 4,792 4,691 5,616
Trade payables and other current liabilities 14,602 14,768 14,391
Current tax liabilities 1,051 898 1,072
Provisions 530 620 665
Liabilities held for sale 1 1 1
Total current liabilities 20,976 20,978 21,745
Non-current liabilities      
Financial liabilities 24,013 23,566 23,369
Non-current tax liabilities 289 182 187
Pensions and post-retirement healthcare liabilities:      
Funded schemes in deficit 1,275 1,157 1,176
Unfunded schemes 1,426 1,461 1,417
Provisions 642 664 637
Deferred tax liabilities 3,276 2,573 2,272
Other non-current liabilities 257 339 330
Total non-current liabilities 31,178 29,942 29,388
Total liabilities 52,154 50,920 51,133
Equity      
Shareholders' equity 15,639 13,192 12,710
Non-controlling interests 2,585 694 686
Total equity 18,224 13,886 13,396
Total liabilities and equity € 70,378 € 64,806 € 64,529
[1] Financial assets exclude trade and other current receivables.
v3.20.2
Consolidated Cash Flow Statement - EUR (€)
€ in Millions
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Statement of cash flows [abstract]    
Net profit € 3,542 € 3,209
Taxation 991 1,145
Share of net (profit)/loss of joint ventures/associates and other (income)/loss from non-current investments and associates (89) (87)
Net monetary (gain)/loss arising from hyperinflationary economies (21) (29)
Net finance costs 249 351
Operating profit 4,672 4,589
Depreciation, amortisation and impairment 987 965
Changes in working capital (1,215) (1,888)
Pensions and similar obligations less payments (79) (94)
Provisions less payments (66) 47
Elimination of (profits)/losses on disposals 45 (36)
Non-cash charge for share-based compensation 74 95
Other adjustments 9 23
Cash flow from operating activities 4,427 3,701
Income tax paid (899) (1,309)
Net cash flow from operating activities 3,528 2,392
Interest received 80 78
Net capital expenditure (422) (558)
Other acquisitions and disposals (623) (470)
Other investing activities 384 234
Net cash flow (used in)/from investing activities (581) (716)
Dividends paid on ordinary share capital (2,120) (2,080)
Interest paid (336) (369)
Change in financial liabilities 602 1,937
Other movements on treasury shares   (205)
Other financing activities (234) (139)
Net cash flow (used in)/from financing activities (2,088) (856)
Net increase/(decrease) in cash and cash equivalents 859 820
Cash and cash equivalents at the beginning of the period 4,116 3,090
Effect of foreign exchange rate changes (253) (121)
Cash and cash equivalents at the end of the period € 4,722 € 3,789
v3.20.2
Accounting Information and Policies
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Accounting Information and Policies
1 ACCOUNTING INFORMATION AND POLICIES
The accounting policies and methods of computation are in compliance with IAS 34 ‘Interim Financial Reporting’ as issued by the International Accounting Standard Board (IASB) and as adopted by the EU; and except as set out below are consistent with the year ended 31 December 2019. The condensed interim financial statements are based on International Financial Reporting Standards (IFRS) as adopted by the EU and IFRS as issued by the IASB.
Management have produced forecasts which have been modelled for different plausible downside scenarios as a result of the
Covid-19
pandemic. These scenarios confirm the Group is able to generate profits and cash in the year ended 31 December 2020 and beyond. As a result, the Directors have a reasonable expectation that the Group has adequate resources to meet its obligations as they fall due for a period of at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the half year financial statements.
The condensed interim financial statements are shown at current exchange rates, while percentage
year-on-year
changes are shown at both current and constant exchange rates to facilitate comparison. The consolidated income statement on page 12, the consolidated statement of comprehensive income on page 12, the consolidated statement of changes in equity on page 13 and the consolidated cash flow statement on page 15 are translated at exchange rates current in each period. The consolidated balance sheet on page 14 is translated at
period-end
rates of exchange.
The condensed interim financial statements attached do not constitute the full financial statements within the meaning of section 434 of the UK Companies Act 2006. The comparative figures for the financial year ended 31 December 2019 are not Unilever PLC’s statutory accounts for that financial year. Those accounts of Unilever for the year ended 31 December 2019 have been reported on by the Group’s auditor and delivered to the Registrar of Companies. The report of the auditor on these accounts was (i) unqualified, (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498 (2) or (3) of the UK Companies Act 2006.
Recent accounting developments
Interest Rate Benchmark Reform - Amendments to IFRS 9, IAS 39 and IFRS 7
The Group has adopted the amendments that modify specific hedge accounting requirements to allow entities to continue to forecast future cash flows assuming that the interest rate benchmark will continue despite ongoing reviews of interest rate benchmark reform. As a result, there is no requirement for an entity to discontinue hedge relationships or to reassess the economic relationships between hedged items and hedging instruments as a result of the uncertainties of the interest rate benchmark reform. The Group does not have material derivatives that refer to an interest rate benchmark so these amendments do not have a material impact on Unilever.
v3.20.2
Significant Items Within the Income Statement
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Significant Items Within the Income Statement
2 SIGNIFICANT ITEMS WITHIN THE INCOME STATEMENT
Non-underlying
items
These include
non-underlying
items within operating profit and
non-underlying
items not in operating profit but with net profit:
 
 
 
Non-underlying
items within operating profit
are gains or losses on business disposals, acquisition and disposal related costs, restructuring costs, impairment and
one-off
items within operating profit.
 
 
 
Non-underlying
items not in operating profit but with net profit
are net monetary gain/(loss) arising from hyperinflationary economies and significant and unusual items in net finance cost, share of profit/(loss) of joint ventures and associates and taxation.
Restructuring costs are charges associated with activities planned by management that significantly change either the scope of the business or the manner in which it is conducted.
 
€ million
  
First Half
 
 
  
2020
 
  
2019
 
Acquisition and disposal-related credit/(costs)
  
 
(27
  
 
(77
Gain/(loss) on disposal of group companies
(a)
  
 
6
 
  
 
66
 
Restructuring costs
  
 
(391
  
 
(454
Impairment
  
 
–  
 
  
 
–  
 
One-off
items
  
 
–  
 
  
 
–  
 
 
  
 
 
 
  
 
 
 
   
Non-underlying
items within operating profit before tax
  
 
(412
  
 
(465
Tax on
non-underlying
items within operating profit
  
 
109
 
  
 
89
 
 
  
 
 
 
  
 
 
 
   
Non-underlying
items within operating profit after tax
  
 
(303
  
 
(376
 
  
 
 
 
  
 
 
 
Share of gain on disposal of Spreads business in Portugal JV
  
 
–  
 
  
 
3
 
Net monetary gain arising from hyperinflationary economies
  
 
21
 
  
 
29
 
 
  
 
 
 
  
 
 
 
   
Non-underlying
items not in operating profit but within net profit before tax
  
 
21
 
  
 
32
 
Tax impact of
non-underlying
items not in operating profit but within net profit:
  
   
  
   
Hyperinflation adjustment for Argentina deferred tax
  
 
(7
  
 
–  
 
 
  
 
 
 
  
 
 
 
   
Non-underlying
items not in operating profit but within net profit after tax
  
 
14
 
  
 
32
 
 
  
 
 
 
  
 
 
 
   
Non-underlying
items after tax
(b)
  
 
(289
  
 
(344
 
  
 
 
 
  
 
 
 
   
Attributable to:
  
   
  
   
Non-controlling
interests
  
 
(14
  
 
(8
Shareholders’ equity
  
 
(275
  
 
(336
 
(a)
2019 includes a gain of
60 million relating to disposal of Alsa baking and dessert business.
(b)
Non-underlying
items after tax is calculated as
non-underlying
items within operating profit after tax plus
non-underlying
items not in operating profit but within net profit after tax.
v3.20.2
Segment Information - Divisions
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Segment Information
3 SEGMENT INFORMATION - DIVISIONS
 
First Half
  
Beauty &
Personal
Care
 
  
Home
Care
 
  
Foods &
Refreshment
 
  
Total
 
Turnover
(
million)
  
   
  
   
  
   
  
   
2019
  
 
10,721
 
  
 
5,410
 
  
 
9,995
 
  
 
26,126
 
2020
  
 
10,610
 
  
 
5,328
 
  
 
9,776
 
  
 
25,714
 
Change (%)
  
 
(1.0
  
 
(1.5
  
 
(2.2
  
 
(1.6
Impact of:
  
   
  
   
  
   
  
   
Acquisitions (%)
  
 
1.3
 
  
 
0.3
 
  
 
1.7
 
  
 
1.2
 
Disposals (%)
  
 
–  
 
  
 
–  
 
  
 
(0.4
  
 
(0.2
Currency-related items (%), of which:
  
 
(2.0
  
 
(4.8
  
 
(1.7
  
 
(2.5
Exchange rates changes (%)
  
 
(2.2
  
 
(5.1
  
 
(2.0
  
 
(2.7
Extreme price growth in hyperinflationary markets* (%)
  
 
0.3
 
  
 
0.3
 
  
 
0.3
 
  
 
0.3
 
Underlying sales growth
(%)
  
 
(0.3
  
 
3.2
 
  
 
(1.7
  
 
(0.1
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Price
*
(%)
  
 
(0.4
  
 
0.3
 
  
 
0.8
 
  
 
0.2
 
Volume (%)
  
 
0.1
 
  
 
2.9
 
  
 
(2.5
  
 
(0.3
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Operating profit
(
million)
  
   
  
   
  
   
  
   
2019
  
 
2,322
 
  
 
652
 
  
 
1,615
 
  
 
4,589
 
2020
  
 
2,403
 
  
 
744
 
  
 
1,525
 
  
 
4,672
 
Underlying operating profit
(
million)
  
   
  
   
  
   
  
   
2019
  
 
2,469
 
  
 
756
 
  
 
1,829
 
  
 
5,054
 
2020
  
 
2,495
 
  
 
817
 
  
 
1,772
 
  
 
5,084
 
Operating margin
(%)
  
   
  
   
  
   
  
   
2019
  
 
21.7
 
  
 
12.1
 
  
 
16.2
 
  
 
17.6
 
2020
  
 
22.6
 
  
 
14.0
 
  
 
15.6
 
  
 
18.2
 
Underlying operating margin
(%)
  
   
  
   
  
   
  
   
2019
  
 
23.0
 
  
 
14.0
 
  
 
18.3
 
  
 
19.3
 
2020
  
 
23.5
 
  
 
15.3
 
  
 
18.1
 
  
 
19.8
 
 
*
Underlying price growth in excess of 26% per year in hyperinflationary economies has been excluded when calculating the price growth in the tables above, and an equal and opposite amount is shown as extreme price growth in hyperinflationary markets.
Turnover growth is made up of distinct individual growth components namely underlying sales, currency impact, acquisitions and disposals. Turnover growth is arrived at by multiplying these individual components on a compounded basis as there is a currency impact on each of the other components. Accordingly, turnover growth is more than just the sum of the individual components.
Underlying operating profit represents our measure of segment profit or loss as it is the primary measure used for the purpose of making decisions about allocating resources and assessing performance of segments. Underlying operating margin is calculated as underlying operating profit divided by turnover.
v3.20.2
Segment Information - Geographical Area
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Segment Information - Geographical Area
4 SEGMENT INFORMATION - GEOGRAPHICAL AREA
 
First Half
  
Asia /
AMET /
RUB
 
  
The
Americas
 
  
Europe
 
  
Total
 
Turnover
(
million)
  
   
  
   
  
   
  
   
2019
  
 
12,195
 
  
 
8,141
 
  
 
5,790
 
  
 
26,126
 
2020
  
 
11,807
 
  
 
8,227
 
  
 
5,680
 
  
 
25,714
 
Change (%)
  
 
(3.2
  
 
1.1
 
  
 
(1.9
  
 
(1.6
Impact of:
  
   
  
   
  
   
  
   
Acquisitions (%)
  
 
1.4
 
  
 
1.5
 
  
 
0.5
 
  
 
1.2
 
Disposals (%)
  
 
(0.2
  
 
(0.1
  
 
(0.3
  
 
(0.2
Currency-related items (%), of which:
  
 
(1.7
  
 
(5.1
  
 
(0.3
  
 
(2.5
Exchange rates changes (%)
  
 
(1.8
  
 
(5.8
  
 
(0.3
  
 
(2.7
Extreme price growth in hyperinflationary markets* (%)
  
 
0.1
 
  
 
0.7
 
  
 
–  
 
  
 
0.3
 
Underlying sales growth
(%)
  
 
(2.7
  
 
5.0
 
  
 
(1.8
  
 
(0.1
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Price
*
(%)
  
 
0.2
 
  
 
0.9
 
  
 
(0.8
  
 
0.2
 
Volume (%)
  
 
(2.9
  
 
4.1
 
  
 
(1.0
  
 
(0.3
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Operating profit
(
million)
  
   
  
   
  
   
  
   
2019
  
 
2,339
 
  
 
1,270
 
  
 
980
 
  
 
4,589
 
2020
  
 
2,265
 
  
 
1,532
 
  
 
875
 
  
 
4,672
 
Underlying operating profit
(
million)
  
   
  
   
  
   
  
   
2019
  
 
2,526
 
  
 
1,425
 
  
 
1,103
 
  
 
5,054
 
2020
  
 
2,394
 
  
 
1,622
 
  
 
1,068
 
  
 
5,084
 
Operating margin
(%)
  
   
  
   
  
   
  
   
2019
  
 
19.2
 
  
 
15.6
 
  
 
16.9
 
  
 
17.6
 
2020
  
 
19.2
 
  
 
18.6
 
  
 
15.4
 
  
 
18.2
 
Underlying operating margin
(%)
  
   
  
   
  
   
  
   
2019
  
 
20.7
 
  
 
17.5
 
  
 
19.1
 
  
 
19.3
 
2020
  
 
20.3
 
  
 
19.7
 
  
 
18.8
 
  
 
19.8
 
 
*
Underlying price growth in excess of 26% per year in hyperinflationary economies has been excluded when calculating the price growth in the tables above, and an equal and opposite amount is shown as extreme price growth in hyperinflationary markets.
v3.20.2
Taxation
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Taxation
5 TAXATION
The effective tax rate for the first half was 22.3% compared to 26.8% in 2019, a decrease primarily driven by favourable tax settlements agreed during the period, a reduction in the India tax rate and replacement of Indian distribution tax with a dividend withholding tax. The tax rate is calculated by dividing the tax charge by
pre-tax
profit excluding the contribution of joint ventures and associates.
Tax effects of components of other comprehensive income were as follows:
 
 
  
First Half 2020
 
 
First Half 2019
 
million
  
Before
tax
 
 
Tax
(charge)/
credit
 
 
After
tax
 
 
Before
tax
 
  
Tax
(charge)/
credit
 
 
After
tax
 
Gains/(losses) on
  
   
 
   
 
   
 
   
  
   
 
   
Equity instruments at fair value through other comprehensive income
  
 
19
 
 
 
1
 
 
 
20
 
 
 
16
 
  
 
–  
 
 
 
16
 
Cash flow hedges
  
 
71
 
 
 
(28
 
 
43
 
 
 
89
 
  
 
(6
 
 
83
 
Remeasurements of defined benefit pension plans
  
 
(242
 
 
41
 
 
 
(201
 
 
274
 
  
 
(7
 
 
267
 
Currency retranslation gains/(losses)
  
 
(1,516
 
 
35
 
 
 
(1,481
 
 
68
 
  
 
(4
 
 
64
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
       
Other comprehensive income
  
 
(1,668
 
 
49
 
 
 
(1,619
 
 
447
 
  
 
(17
 
 
430
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
v3.20.2
Combined Earnings Per Share
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Combined Earnings Per Share
6 COMBINED EARNINGS PER SHARE
 
 
  
2020
 
  
2019
 
Combined EPS – Basic
  
   
  
   
Net profit attributable to shareholders’ equity (
million)
  
 
3,284
 
  
 
3,006
 
Average number of combined share units (millions of units)
  
 
2,619.0
 
  
 
2,616.5
 
Combined EPS – basic (
)
  
 
1.25
 
  
 
1.15
 
   
Combined EPS – Diluted
  
   
  
   
Net profit attributable to shareholders’ equity (
million)
  
 
3,284
 
  
 
3,006
 
Adjusted average number of combined share units (millions of units)
  
 
2,627.2
 
  
 
2,625.6
 
Combined EPS – diluted (
)
  
 
1.25
 
  
 
1.14
 
   
Underlying EPS
  
   
  
   
Net profit attributable to shareholder’s equity (
million)
  
 
3,284
 
  
 
3,006
 
Post tax impact of
non-underlying
items attributable to shareholders’ equity (see note 2)
  
 
275
 
  
 
336
 
 
  
 
 
 
  
 
 
 
Underlying profit attributable to shareholders’ equity (
million)
  
 
3,559
 
  
 
3,342
 
Adjusted average number of combined share units (millions of units)
  
 
2,627.2
 
  
 
2,625.6
 
Underlying EPS – diluted (
)
  
 
1.35
 
  
 
1.27
 
In calculating underlying earnings per share, net profit attributable to shareholders’ equity is adjusted to eliminate the
post-tax
impact of
non-underlying
items.
During the period the following movements in shares have taken place:
 
 
  
Millions
 
Number of shares at 31 December 2019 (net of treasury shares)
  
 
2,616.8
 
Net movement in shares under incentive schemes
  
 
4.5
 
 
  
 
 
 
Number of shares at 30 June 2020
  
 
2,621.3
 
 
  
 
 
 
 
 
v3.20.2
Acquisitions and Disposals
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Acquisitions and Disposals
7 ACQUISITIONS AND DISPOSALS
Total consideration for acquisitions completed in the first half of 2020 is
5,526 million (acquisitions completed in the first half of 2019:
654 million). A material acquisition in the first half of 2020 was the purchase of the health food drinks portfolio of GlaxoSmithKline plc in India and 20 other predominantly Asian markets (“the Main Horlicks Acquisition”). There were no other significant acquisitions completed in the first half of 2020.
Horlicks Acquisitions
The Main Horlicks Acquisition was composed of the following related transactions on 1 April 2020:
 
 
Hindustan Unilever Limited (HUL), a subsidiary of the Group, obtained control of the business of GlaxoSmithKline Consumer Healthcare Limited (GSKCH) via an all equity merger under which 4.39 shares of HUL were allotted for every share of GSKCH;
 
 
HUL purchased the Horlicks intellectual property rights, being mainly legal rights to the Horlicks brand (the ‘HFD IP’) for India and Unilever N.V. and Unilever PLC purchased the HFD IP outside of India and Bangladesh; and
 
 
Unilever Foods (Malaysia) Sdn Bhd and Unilever Asia Pacific Limited (Singapore) purchased the Horlicks commercial operations of GSK in 20 other predominantly Asian markets (“Local Distribution Assets”).
The Bangladesh Horlicks Acquisition is separate to the Main Horlicks Acquisition and completed on 30 June 2020. Unilever Overseas Holding B.V. purchased 82% of GSK Bangladesh Limited and Unilever PLC purchased the HFD IP in Bangladesh. The following disclosures relate only to the Main Horlicks Acquisition.
Main Horlicks Acquisition
The purpose of the acquisition was to add the Horlicks and Boost brands in certain geographical markets to Unilever’s portfolio to increase presence in healthy nutrition and in high-growth emerging markets.
Effect on consolidated income statement
The acquisition contributed
142 million to Group turnover and
39 million to Group operating profit since the acquisition date. If the acquisition had taken place at the beginning of the year, Group turnover would have been
25,856 million and Group operating profit would have been
4,711 million.
Effect on consolidated balance sheet
The
5,294 million consideration comprised of
449 million in cash and
4,845 million in shares of Hindustan Unilever Limited valued based on the share price of HUL on the completion date and the exchange rate on the same date (83.05 INR/
).
The fair value of the net assets acquired are set out in the table below. The amounts are provisional and subject to change.
 
 
  
 million
 
Intangible assets
  
 
3,345
 
Other
non-current
assets
  
 
249
 
Deferred tax (net)
  
 
(746
Other financial assets
  
 
463
 
Trade and other receivables
  
 
74
 
Other current assets
  
 
94
 
Non-current
liabilities
  
 
(159
Current liabilities
  
 
(122
 
  
 
 
 
Net assets acquired
  
 
3,198
 
Goodwill
  
 
2,096
 
 
  
 
 
 
Total consideration
  
 
5,294
 
 
  
 
 
 
Net cash outflow arising on acquisition:
  
   
Cash consideration
  
 
(449
Less cash and cash equivalents acquired
  
 
36
 
 
  
 
 
 
Total outflow in the consolidated statement of cash flows
  
 
(413
Goodwill represents the future value which the Group believes it will obtain through operational synergies, such as the overlapping distribution network, tax benefits on goodwill and working capital improvements and leveraging from the competencies and capabilities of the Horlicks brand presence and recognition to generate stronger market power. We expect around
1.3 billion of the goodwill to be deductible for tax purposes. While we believe there is legal basis to claim the Horlicks goodwill as tax deductible, we expect challenges to this from the Indian tax authorities. Since the acquisition date, foreign exchange has decreased this goodwill in euros by
44 million.
The gross contractual value of trade and other receivables as at the dates of acquisition amounted to
74 million which is expected to be fully recoverable.
Within the acquired net assets, contingent liabilities amounting to
123 million in respect of ongoing litigation against GlaxoSmithKline Consumer Healthcare Limited have been recognised based on management’s estimate of the values of exposures and their assessment of the probability of the related claims being settled by the Group. The contingent liabilities mainly relate to direct and indirect tax disputes with the Indian tax authorities. There are several matters being disputed and in each case we believe that the likelihood that the Indian tax authorities will ultimately prevail is no higher than moderate, however we expect that most of these disputes will not be resolved for several years. Contingent assets of
73 million are also recognised, measured on the same basis, for the Group’s right to future indemnification by GlaxoSmithKline Pte Limited and Horlicks Limited in relation to certain claims.
Acquisition-related costs of
29 million have been recorded within
non-underlying
items in the consolidated income statement for the half year period to 30 June 2020 (full year 2019:
12 million). Total costs relating to the issuance of shares amounting to
5 million have been recognised against equity by Hindustan Unilever Limited.
Impact of dilution of Group interest in Hindustan Unilever Limited
The acquisition of GSKCH by HUL was settled through the issue of (184.6 million) new shares of Hindustan Unilever Limited and so resulted in dilution of Unilever’s interest in Hindustan Unilever Limited from 67.2% to 61.9%. The table below shows the impact of the decrease in shareholding on the equity attributable to shareholders of the Group.
 
 
  
 million
 
67.2% share of HUL’s net assets acquired before acquisition of GSKCH
  
 
718
 
61.9% share of HUL’s net assets acquired after acquisition of GSKCH
  
 
661
 
 
  
 
 
 
Loss recognised in equity due to dilution
  
 
(57
Gain arising from proportionate share of GSKCH’s net assets acquired
  
 
3,001
 
 
  
 
 
 
Net gain arising from the Main Horlicks acquisition recognized in equity
  
 
2,944
 
v3.20.2
Financial Instruments
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Financial Instruments
8 FINANCIAL INSTRUMENTS
The Group’s Treasury function aims to protect the Group’s financial investments, while maximising returns. The fair value of financial assets is the same as the carrying amount for 2020 and 2019. The Group’s cash resources and other financial assets are shown below.
 
€ million
 
30 June 2020
 
 
31 December 2019
 
 
30 June 2019
 
 
 
Current
 
 
Non-current
 
 
Total
 
 
Current
 
 
Non-current
 
 
Total
 
 
Current
 
 
Non-current
 
 
Total
 
Cash and cash equivalents
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
Cash at bank and in hand
 
 
2,672
 
 
 
–  
 
 
 
2,672
 
 
 
2,457
 
 
 
–  
 
 
 
2,457
 
 
 
2,157
 
 
 
–  
 
 
 
2,157
 
Short-term deposits with maturity of three months or less
 
 
2,176
 
 
 
–  
 
 
 
2,176
 
 
 
1,693
 
 
 
–  
 
 
 
1,693
 
 
 
1,568
 
 
 
–  
 
 
 
1,568
 
Other cash equivalents
 
 
7
 
 
 
–  
 
 
 
7
 
 
 
35
 
 
 
–  
 
 
 
35
 
 
 
186
 
 
 
–  
 
 
 
186
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
 
 
 
4,855
 
 
 
–  
 
 
 
4,855
 
 
 
4,185
 
 
 
 
 
 
4,185
 
 
 
3,911
 
 
 
 
 
 
3,911
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other financial assets
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
Financial assets at amortised cost
(a)
 
 
774
 
 
 
129
 
 
 
903
 
 
 
578
 
 
 
220
 
 
 
798
 
 
 
239
 
 
 
260
 
 
 
499
 
Financial assets at fair value through other comprehensive income
(b)
 
 
–  
 
 
 
304
 
 
 
304
 
 
 
–  
 
 
 
266
 
 
 
266
 
 
 
110
 
 
 
217
 
 
 
327
 
Financial assets at fair value through profit or loss:
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
Derivatives that relate to financial liabilities
 
 
69
 
 
 
96
 
 
 
165
 
 
 
20
 
 
 
114
 
 
 
134
 
 
 
411
 
 
 
–  
 
 
 
411
 
Other
(c)
 
 
257
 
 
 
286
 
 
 
543
 
 
 
309
 
 
 
274
 
 
 
583
 
 
 
153
 
 
 
228
 
 
 
381
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
 
 
 
1,100
 
 
 
815
 
 
 
1,915
 
 
 
907
 
 
 
874
 
 
 
1,781
 
 
 
913
 
 
 
705
 
 
 
1,618
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
Total financial assets
(d)
 
 
5,955
 
 
 
815
 
 
 
6,770
 
 
 
5,092
 
 
 
874
 
 
 
5,966
 
 
 
4,824
 
 
 
705
 
 
 
5,529
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a)
Current financial assets at amortised cost include short term deposits with banks with maturities longer than three months and loans to joint venture entities.
Non-current
financial assets at amortised cost include judicial deposit of
94 million (December 2019:
136 million) and investment in bonds of
nil million (December 2019:
56 million).
(b)
Included within
non-current
financial assets at fair value through other comprehensive income are equity investments of
284 million (December 2019:
244 million).
(c)
Included within current financial assets at fair value through profit or loss are highly liquid debt mutual funds. Included within
non-current
financial assets at fair value through profit or loss are assets in a trust to fund benefit obligations in the US and investments in a number of companies and financial institutions in North America, North Asia, South Asia and Europe.
(d)
Financial assets exclude trade and other current receivables.
The Group is exposed to the risks of changes in fair value of its financial assets and liabilities. The following tables summarise the fair values and carrying amounts of financial instruments and the fair value calculations by category.
 
 
  
Fair value
 
 
Carrying amount
 
€ million
  
As at
30 June
2020
 
 
As at
31 December
2019
 
 
As at
30 June
2019
 
 
As at
30 June
2020
 
 
As at
31 December
2019
 
 
As at
30 June
2019
 
Financial assets
  
   
 
   
 
   
 
   
 
   
 
   
Cash and cash equivalents
  
 
4,855
 
 
 
4,185
 
 
 
3,911
 
 
 
4,855
 
 
 
4,185
 
 
 
3,911
 
Financial assets at amortised cost
  
 
903
 
 
 
798
 
 
 
499
 
 
 
903
 
 
 
798
 
 
 
499
 
Financial assets at fair value through other comprehensive income
  
 
304
 
 
 
266
 
 
 
327
 
 
 
304
 
 
 
266
 
 
 
327
 
Financial assets at fair value through profit and loss:
  
   
 
   
 
   
 
   
 
   
 
   
Derivatives
  
 
165
 
 
 
134
 
 
 
411
 
 
 
165
 
 
 
134
 
 
 
411
 
Other
  
 
543
 
 
 
583
 
 
 
381
 
 
 
543
 
 
 
583
 
 
 
381
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
  
 
6,770
 
 
 
5,966
 
 
 
5,529
 
 
 
6,770
 
 
 
5,966
 
 
 
5,529
 
Financial liabilities
  
   
 
   
 
   
 
   
 
   
 
   
Bank loans and overdrafts
  
 
(851
 
 
(853
 
 
(1,044
 
 
(851
 
 
(853
 
 
(1,041
Bonds and other loans
  
 
(28,206
 
 
(26,525
 
 
(26,787
 
 
(25,837
 
 
(25,032
 
 
(25,390
Lease liabilities
  
 
(1,849
 
 
(1,919
 
 
(1,967
 
 
(1,849
 
 
(1,919
 
 
(1,967
Derivatives
  
 
(76
 
 
(270
 
 
(464
 
 
(76
 
 
(270
 
 
(464
Other financial liabilities
  
 
(192
 
 
(183
 
 
(123
 
 
(192
 
 
(183
 
 
(123
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
  
 
(31,174
 
 
(29,750
 
 
(30,385
 
 
(28,805
 
 
(28,257
 
 
(28,985
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Level 1
 
  
Level 2
 
 
Level 3
 
 
Level 1
 
  
Level 2
 
 
Level 3
 
 
Level 1
 
  
Level 2
 
 
Level 3
 
€ million
  
As at 30 June 2020
 
 
As at 31 December 2019
 
 
As at 30 June 2019
 
Assets at fair value
  
   
  
   
 
   
 
   
  
   
 
   
 
   
  
   
 
   
Financial assets at fair value through other comprehensive income
  
 
5
 
  
 
4
 
 
 
295
 
 
 
7
 
  
 
4
 
 
 
255
 
 
 
116
 
  
 
4
 
 
 
207
 
Financial assets at fair value through profit or loss:
  
   
  
   
 
   
 
   
  
   
 
   
 
   
  
   
 
   
Derivatives
(a)
  
 
–  
 
  
 
268
 
 
 
–  
 
 
 
–  
 
  
 
208
 
 
 
–  
 
 
 
–  
 
  
 
448
 
 
 
–  
 
Other
  
 
260
 
  
 
–  
 
 
 
283
 
 
 
311
 
  
 
–  
 
 
 
272
 
 
 
155
 
  
 
–  
 
 
 
226
 
Liabilities at fair value
  
   
  
   
 
   
 
   
  
   
 
   
 
   
  
   
 
   
Derivatives
(b)
  
 
–  
 
  
 
(187
 
 
–  
 
 
 
–  
 
  
 
(326
 
 
–  
 
 
 
–  
 
  
 
(530
 
 
–  
 
Contingent Consideration
  
 
–  
 
  
 
–  
 
 
 
(155
 
 
–  
 
  
 
–  
 
 
 
(154
 
 
–  
 
  
 
–  
 
 
 
(156
 
(a)
Includes
103 million (December 2019:
74 million, June 2019:
37 million) derivatives, reported within trade receivables, that hedge trading activities.
(b)
Includes
(111) million (December 2019:
 (56) million, June 2019:
(66) million) derivatives, reported within trade payables, that hedge trading activities.
There were no significant changes in classification of fair value of financial assets and financial liabilities since 31 December 2019. There were also no significant movements between the fair value hierarchy classifications since 31 December 2019.
The fair value of trade receivables and payables is considered to be equal to the carrying amount of these items due to their short-term nature.
Calculation of fair values
The fair values of the financial assets and liabilities are defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Methods and assumptions used to estimate the fair values are consistent with those used in the year ended 31 December 2019.
v3.20.2
Dividends
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Dividends
9 DIVIDENDS
The Boards have determined to pay a quarterly interim dividend for Q1 2020 and Q2 2020 at the following rates which are equivalent in value between the two companies at the rate of exchange applied under the terms of the Equalisation Agreement:
 
 
  
Q1 2020
 
  
Q2 2020
 
Per Unilever N.V. ordinary share
  
0.4104
 
  
0.4104
 
Per Unilever PLC ordinary share
  
£
0.3614
 
  
£
0.3698
 
Per Unilever N.V. New York share
  
US$
0.4445
 
  
US$
0.4694
 
Per Unilever PLC American Depositary Receipt
  
US$
 0.4445
 
  
US$
 0.4694
 
The quarterly interim dividends have been determined in euros and converted into equivalent sterling and US dollar amounts using exchange rates issued by WM/Reuters on 21 April 2020 and 21 July 2020 for Q1 and Q2 respectively.
US dollar cheques for Q2 interim dividend will be mailed on 9 September 2020 to holders of record at the close of business on 7 August 2020. In the case of the NV New York shares, Netherlands withholding tax will be deducted.
The quarterly dividend calendar for the remainder of 2020 will be as follows:
 
 
  
Announcement
Date
  
Ex-Dividend
Date
  
Record Date
  
Payment Date
Q2 2020 Dividend
  
23 July 2020
  
6 August 2020
  
7 August 2020
  
9 September 2020
Q3 2020 Dividend
  
22 October 2020
  
5 November 2020
  
6 November 2020
  
2 December 2020
 
v3.20.2
Events After The Balance Sheet Date
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Events After The Balance Sheet Date
10 EVENTS AFTER THE BALANCE SHEET DATE
There were no material post balance sheet events other than those mentioned elsewhere in this report.
v3.20.2
Accounting Information and Policies (Policies)
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Accounting information and policies
The accounting policies and methods of computation are in compliance with IAS 34 ‘Interim Financial Reporting’ as issued by the International Accounting Standard Board (IASB) and as adopted by the EU; and except as set out below are consistent with the year ended 31 December 2019. The condensed interim financial statements are based on International Financial Reporting Standards (IFRS) as adopted by the EU and IFRS as issued by the IASB.
Management have produced forecasts which have been modelled for different plausible downside scenarios as a result of the
Covid-19
pandemic. These scenarios confirm the Group is able to generate profits and cash in the year ended 31 December 2020 and beyond. As a result, the Directors have a reasonable expectation that the Group has adequate resources to meet its obligations as they fall due for a period of at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the half year financial statements.
The condensed interim financial statements are shown at current exchange rates, while percentage
year-on-year
changes are shown at both current and constant exchange rates to facilitate comparison. The consolidated income statement on page 12, the consolidated statement of comprehensive income on page 12, the consolidated statement of changes in equity on page 13 and the consolidated cash flow statement on page 15 are translated at exchange rates current in each period. The consolidated balance sheet on page 14 is translated at
period-end
rates of exchange.
The condensed interim financial statements attached do not constitute the full financial statements within the meaning of section 434 of the UK Companies Act 2006. The comparative figures for the financial year ended 31 December 2019 are not Unilever PLC’s statutory accounts for that financial year. Those accounts of Unilever for the year ended 31 December 2019 have been reported on by the Group’s auditor and delivered to the Registrar of Companies. The report of the auditor on these accounts was (i) unqualified, (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498 (2) or (3) of the UK Companies Act 2006.
Recent accounting developments
Recent accounting developments
Interest Rate Benchmark Reform - Amendments to IFRS 9, IAS 39 and IFRS 7
The Group has adopted the amendments that modify specific hedge accounting requirements to allow entities to continue to forecast future cash flows assuming that the interest rate benchmark will continue despite ongoing reviews of interest rate benchmark reform. As a result, there is no requirement for an entity to discontinue hedge relationships or to reassess the economic relationships between hedged items and hedging instruments as a result of the uncertainties of the interest rate benchmark reform. The Group does not have material derivatives that refer to an interest rate benchmark so these amendments do not have a material impact on Unilever.
v3.20.2
Significant Items Within the Income Statement (Tables)
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Non-underlying Items
 
€ million
  
First Half
 
 
  
2020
 
  
2019
 
Acquisition and disposal-related credit/(costs)
  
 
(27
  
 
(77
Gain/(loss) on disposal of group companies
(a)
  
 
6
 
  
 
66
 
Restructuring costs
  
 
(391
  
 
(454
Impairment
  
 
–  
 
  
 
–  
 
One-off
items
  
 
–  
 
  
 
–  
 
 
  
 
 
 
  
 
 
 
   
Non-underlying
items within operating profit before tax
  
 
(412
  
 
(465
Tax on
non-underlying
items within operating profit
  
 
109
 
  
 
89
 
 
  
 
 
 
  
 
 
 
   
Non-underlying
items within operating profit after tax
  
 
(303
  
 
(376
 
  
 
 
 
  
 
 
 
Share of gain on disposal of Spreads business in Portugal JV
  
 
–  
 
  
 
3
 
Net monetary gain arising from hyperinflationary economies
  
 
21
 
  
 
29
 
 
  
 
 
 
  
 
 
 
   
Non-underlying
items not in operating profit but within net profit before tax
  
 
21
 
  
 
32
 
Tax impact of
non-underlying
items not in operating profit but within net profit:
  
   
  
   
Hyperinflation adjustment for Argentina deferred tax
  
 
(7
  
 
–  
 
 
  
 
 
 
  
 
 
 
   
Non-underlying
items not in operating profit but within net profit after tax
  
 
14
 
  
 
32
 
 
  
 
 
 
  
 
 
 
   
Non-underlying
items after tax
(b)
  
 
(289
  
 
(344
 
  
 
 
 
  
 
 
 
   
Attributable to:
  
   
  
   
Non-controlling
interests
  
 
(14
  
 
(8
Shareholders’ equity
  
 
(275
  
 
(336
 
(a)
2019 includes a gain of
60 million relating to disposal of Alsa baking and dessert business.
(b)
Non-underlying
items after tax is calculated as
non-underlying
items within operating profit after tax plus
non-underlying
items not in operating profit but within net profit after tax.
v3.20.2
Segment Information - Divisions (Tables)
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Summary of Operating Results of Reportable Segments
First Half
  
Beauty &
Personal
Care
 
  
Home
Care
 
  
Foods &
Refreshment
 
  
Total
 
Turnover
(
million)
  
   
  
   
  
   
  
   
2019
  
 
10,721
 
  
 
5,410
 
  
 
9,995
 
  
 
26,126
 
2020
  
 
10,610
 
  
 
5,328
 
  
 
9,776
 
  
 
25,714
 
Change (%)
  
 
(1.0
  
 
(1.5
  
 
(2.2
  
 
(1.6
Impact of:
  
   
  
   
  
   
  
   
Acquisitions (%)
  
 
1.3
 
  
 
0.3
 
  
 
1.7
 
  
 
1.2
 
Disposals (%)
  
 
–  
 
  
 
–  
 
  
 
(0.4
  
 
(0.2
Currency-related items (%), of which:
  
 
(2.0
  
 
(4.8
  
 
(1.7
  
 
(2.5
Exchange rates changes (%)
  
 
(2.2
  
 
(5.1
  
 
(2.0
  
 
(2.7
Extreme price growth in hyperinflationary markets* (%)
  
 
0.3
 
  
 
0.3
 
  
 
0.3
 
  
 
0.3
 
Underlying sales growth
(%)
  
 
(0.3
  
 
3.2
 
  
 
(1.7
  
 
(0.1
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Price
*
(%)
  
 
(0.4
  
 
0.3
 
  
 
0.8
 
  
 
0.2
 
Volume (%)
  
 
0.1
 
  
 
2.9
 
  
 
(2.5
  
 
(0.3
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Operating profit
(
million)
  
   
  
   
  
   
  
   
2019
  
 
2,322
 
  
 
652
 
  
 
1,615
 
  
 
4,589
 
2020
  
 
2,403
 
  
 
744
 
  
 
1,525
 
  
 
4,672
 
Underlying operating profit
(
million)
  
   
  
   
  
   
  
   
2019
  
 
2,469
 
  
 
756
 
  
 
1,829
 
  
 
5,054
 
2020
  
 
2,495
 
  
 
817
 
  
 
1,772
 
  
 
5,084
 
Operating margin
(%)
  
   
  
   
  
   
  
   
2019
  
 
21.7
 
  
 
12.1
 
  
 
16.2
 
  
 
17.6
 
2020
  
 
22.6
 
  
 
14.0
 
  
 
15.6
 
  
 
18.2
 
Underlying operating margin
(%)
  
   
  
   
  
   
  
   
2019
  
 
23.0
 
  
 
14.0
 
  
 
18.3
 
  
 
19.3
 
2020
  
 
23.5
 
  
 
15.3
 
  
 
18.1
 
  
 
19.8
 
 
*
Underlying price growth in excess of 26% per year in hyperinflationary economies has been excluded when calculating the price growth in the tables above, and an equal and opposite amount is shown as extreme price growth in hyperinflationary markets.
v3.20.2
Segment Information - Geographical Area (Tables)
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Summary of Operating Results by Geographical Areas
 
First Half
  
Asia /
AMET /
RUB
 
  
The
Americas
 
  
Europe
 
  
Total
 
Turnover
(
million)
  
   
  
   
  
   
  
   
2019
  
 
12,195
 
  
 
8,141
 
  
 
5,790
 
  
 
26,126
 
2020
  
 
11,807
 
  
 
8,227
 
  
 
5,680
 
  
 
25,714
 
Change (%)
  
 
(3.2
  
 
1.1
 
  
 
(1.9
  
 
(1.6
Impact of:
  
   
  
   
  
   
  
   
Acquisitions (%)
  
 
1.4
 
  
 
1.5
 
  
 
0.5
 
  
 
1.2
 
Disposals (%)
  
 
(0.2
  
 
(0.1
  
 
(0.3
  
 
(0.2
Currency-related items (%), of which:
  
 
(1.7
  
 
(5.1
  
 
(0.3
  
 
(2.5
Exchange rates changes (%)
  
 
(1.8
  
 
(5.8
  
 
(0.3
  
 
(2.7
Extreme price growth in hyperinflationary markets* (%)
  
 
0.1
 
  
 
0.7
 
  
 
–  
 
  
 
0.3
 
Underlying sales growth
(%)
  
 
(2.7
  
 
5.0
 
  
 
(1.8
  
 
(0.1
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Price
*
(%)
  
 
0.2
 
  
 
0.9
 
  
 
(0.8
  
 
0.2
 
Volume (%)
  
 
(2.9
  
 
4.1
 
  
 
(1.0
  
 
(0.3
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Operating profit
(
million)
  
   
  
   
  
   
  
   
2019
  
 
2,339
 
  
 
1,270
 
  
 
980
 
  
 
4,589
 
2020
  
 
2,265
 
  
 
1,532
 
  
 
875
 
  
 
4,672
 
Underlying operating profit
(
million)
  
   
  
   
  
   
  
   
2019
  
 
2,526
 
  
 
1,425
 
  
 
1,103
 
  
 
5,054
 
2020
  
 
2,394
 
  
 
1,622
 
  
 
1,068
 
  
 
5,084
 
Operating margin
(%)
  
   
  
   
  
   
  
   
2019
  
 
19.2
 
  
 
15.6
 
  
 
16.9
 
  
 
17.6
 
2020
  
 
19.2
 
  
 
18.6
 
  
 
15.4
 
  
 
18.2
 
Underlying operating margin
(%)
  
   
  
   
  
   
  
   
2019
  
 
20.7
 
  
 
17.5
 
  
 
19.1
 
  
 
19.3
 
2020
  
 
20.3
 
  
 
19.7
 
  
 
18.8
 
  
 
19.8
 
 
*
Underlying price growth in excess of 26% per year in hyperinflationary economies has been excluded when calculating the price growth in the tables above, and an equal and opposite amount is shown as extreme price growth in hyperinflationary markets.
v3.20.2
Taxation (Tables)
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Summary of Tax Effects of Components of Other Comprehensive Income
Tax effects of components of other comprehensive income were as follows:
 
 
  
First Half 2020
 
 
First Half 2019
 
million
  
Before
tax
 
 
Tax
(charge)/
credit
 
 
After
tax
 
 
Before
tax
 
  
Tax
(charge)/
credit
 
 
After
tax
 
Gains/(losses) on
  
   
 
   
 
   
 
   
  
   
 
   
Equity instruments at fair value through other comprehensive income
  
 
19
 
 
 
1
 
 
 
20
 
 
 
16
 
  
 
–  
 
 
 
16
 
Cash flow hedges
  
 
71
 
 
 
(28
 
 
43
 
 
 
89
 
  
 
(6
 
 
83
 
Remeasurements of defined benefit pension plans
  
 
(242
 
 
41
 
 
 
(201
 
 
274
 
  
 
(7
 
 
267
 
Currency retranslation gains/(losses)
  
 
(1,516
 
 
35
 
 
 
(1,481
 
 
68
 
  
 
(4
 
 
64
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
       
Other comprehensive income
  
 
(1,668
 
 
49
 
 
 
(1,619
 
 
447
 
  
 
(17
 
 
430
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
v3.20.2
Combined Earnings Per Share (Tables)
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Summary of Computation of Earnings Per Share
 
  
2020
 
  
2019
 
Combined EPS – Basic
  
   
  
   
Net profit attributable to shareholders’ equity (
million)
  
 
3,284
 
  
 
3,006
 
Average number of combined share units (millions of units)
  
 
2,619.0
 
  
 
2,616.5
 
Combined EPS – basic (
)
  
 
1.25
 
  
 
1.15
 
   
Combined EPS – Diluted
  
   
  
   
Net profit attributable to shareholders’ equity (
million)
  
 
3,284
 
  
 
3,006
 
Adjusted average number of combined share units (millions of units)
  
 
2,627.2
 
  
 
2,625.6
 
Combined EPS – diluted (
)
  
 
1.25
 
  
 
1.14
 
   
Underlying EPS
  
   
  
   
Net profit attributable to shareholder’s equity (
million)
  
 
3,284
 
  
 
3,006
 
Post tax impact of
non-underlying
items attributable to shareholders’ equity (see note 2)
  
 
275
 
  
 
336
 
 
  
 
 
 
  
 
 
 
Underlying profit attributable to shareholders’ equity (
million)
  
 
3,559
 
  
 
3,342
 
Adjusted average number of combined share units (millions of units)
  
 
2,627.2
 
  
 
2,625.6
 
Underlying EPS – diluted (
)
  
 
1.35
 
  
 
1.27
 
During the period the following movements in shares have taken place:
 
 
  
Millions
 
Number of shares at 31 December 2019 (net of treasury shares)
  
 
2,616.8
 
Net movement in shares under incentive schemes
  
 
4.5
 
 
  
 
 
 
Number of shares at 30 June 2020
  
 
2,621.3
 
 
  
 
 
 
 
 
v3.20.2
Acquisitions and Disposals (Tables)
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Effect of Acquisitions on Consolidated Balance Sheet
The fair value of the net assets acquired are set out in the table below. The amounts are provisional and subject to change.
 
 
  
 million
 
Intangible assets
  
 
3,345
 
Other
non-current
assets
  
 
249
 
Deferred tax (net)
  
 
(746
Other financial assets
  
 
463
 
Trade and other receivables
  
 
74
 
Other current assets
  
 
94
 
Non-current
liabilities
  
 
(159
Current liabilities
  
 
(122
 
  
 
 
 
Net assets acquired
  
 
3,198
 
Goodwill
  
 
2,096
 
 
  
 
 
 
Total consideration
  
 
5,294
 
 
  
 
 
 
Net cash outflow arising on acquisition:
  
   
Cash consideration
  
 
(449
Less cash and cash equivalents acquired
  
 
36
 
 
  
 
 
 
Total outflow in the consolidated statement of cash flows
  
 
(413
Summary of Impact of the Decrease in Shareholding on the Equity Attributable to Shareholders of the Group The table below shows the impact of the decrease in shareholding on the equity attributable to shareholders of the Group.
 
 
  
 million
 
67.2% share of HUL’s net assets acquired before acquisition of GSKCH
  
 
718
 
61.9% share of HUL’s net assets acquired after acquisition of GSKCH
  
 
661
 
 
  
 
 
 
Loss recognised in equity due to dilution
  
 
(57
Gain arising from proportionate share of GSKCH’s net assets acquired
  
 
3,001
 
 
  
 
 
 
Net gain arising from the Main Horlicks acquisition recognized in equity
  
 
2,944
 
v3.20.2
Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Schedule of Cash Resources and Other Financial Assets
The Group’s Treasury function aims to protect the Group’s financial investments, while maximising returns. The fair value of financial assets is the same as the carrying amount for 2020 and 2019. The Group’s cash resources and other financial assets are shown below.
 
€ million
 
30 June 2020
 
 
31 December 2019
 
 
30 June 2019
 
 
 
Current
 
 
Non-current
 
 
Total
 
 
Current
 
 
Non-current
 
 
Total
 
 
Current
 
 
Non-current
 
 
Total
 
Cash and cash equivalents
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
Cash at bank and in hand
 
 
2,672
 
 
 
–  
 
 
 
2,672
 
 
 
2,457
 
 
 
–  
 
 
 
2,457
 
 
 
2,157
 
 
 
–  
 
 
 
2,157
 
Short-term deposits with maturity of three months or less
 
 
2,176
 
 
 
–  
 
 
 
2,176
 
 
 
1,693
 
 
 
–  
 
 
 
1,693
 
 
 
1,568
 
 
 
–  
 
 
 
1,568
 
Other cash equivalents
 
 
7
 
 
 
–  
 
 
 
7
 
 
 
35
 
 
 
–  
 
 
 
35
 
 
 
186
 
 
 
–  
 
 
 
186
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
 
 
 
4,855
 
 
 
–  
 
 
 
4,855
 
 
 
4,185
 
 
 
 
 
 
4,185
 
 
 
3,911
 
 
 
 
 
 
3,911
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other financial assets
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
Financial assets at amortised cost
(a)
 
 
774
 
 
 
129
 
 
 
903
 
 
 
578
 
 
 
220
 
 
 
798
 
 
 
239
 
 
 
260
 
 
 
499
 
Financial assets at fair value through other comprehensive income
(b)
 
 
–  
 
 
 
304
 
 
 
304
 
 
 
–  
 
 
 
266
 
 
 
266
 
 
 
110
 
 
 
217
 
 
 
327
 
Financial assets at fair value through profit or loss:
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
Derivatives that relate to financial liabilities
 
 
69
 
 
 
96
 
 
 
165
 
 
 
20
 
 
 
114
 
 
 
134
 
 
 
411
 
 
 
–  
 
 
 
411
 
Other
(c)
 
 
257
 
 
 
286
 
 
 
543
 
 
 
309
 
 
 
274
 
 
 
583
 
 
 
153
 
 
 
228
 
 
 
381
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
 
 
 
1,100
 
 
 
815
 
 
 
1,915
 
 
 
907
 
 
 
874
 
 
 
1,781
 
 
 
913
 
 
 
705
 
 
 
1,618
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
Total financial assets
(d)
 
 
5,955
 
 
 
815
 
 
 
6,770
 
 
 
5,092
 
 
 
874
 
 
 
5,966
 
 
 
4,824
 
 
 
705
 
 
 
5,529
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a)
Current financial assets at amortised cost include short term deposits with banks with maturities longer than three months and loans to joint venture entities.
Non-current
financial assets at amortised cost include judicial deposit of
94 million (December 2019:
136 million) and investment in bonds of
nil million (December 2019:
56 million).
(b)
Included within
non-current
financial assets at fair value through other comprehensive income are equity investments of
284 million (December 2019:
244 million).
(c)
Included within current financial assets at fair value through profit or loss are highly liquid debt mutual funds. Included within
non-current
financial assets at fair value through profit or loss are assets in a trust to fund benefit obligations in the US and investments in a number of companies and financial institutions in North America, North Asia, South Asia and Europe.
(d)
Financial assets exclude trade and other current receivables.
Summary of Fair Values of Financial Assets and Financial Liabilities
The Group is exposed to the risks of changes in fair value of its financial assets and liabilities. The following tables summarise the fair values and carrying amounts of financial instruments and the fair value calculations by category.
 
 
  
Fair value
 
 
Carrying amount
 
€ million
  
As at
30 June
2020
 
 
As at
31 December
2019
 
 
As at
30 June
2019
 
 
As at
30 June
2020
 
 
As at
31 December
2019
 
 
As at
30 June
2019
 
Financial assets
  
   
 
   
 
   
 
   
 
   
 
   
Cash and cash equivalents
  
 
4,855
 
 
 
4,185
 
 
 
3,911
 
 
 
4,855
 
 
 
4,185
 
 
 
3,911
 
Financial assets at amortised cost
  
 
903
 
 
 
798
 
 
 
499
 
 
 
903
 
 
 
798
 
 
 
499
 
Financial assets at fair value through other comprehensive income
  
 
304
 
 
 
266
 
 
 
327
 
 
 
304
 
 
 
266
 
 
 
327
 
Financial assets at fair value through profit and loss:
  
   
 
   
 
   
 
   
 
   
 
   
Derivatives
  
 
165
 
 
 
134
 
 
 
411
 
 
 
165
 
 
 
134
 
 
 
411
 
Other
  
 
543
 
 
 
583
 
 
 
381
 
 
 
543
 
 
 
583
 
 
 
381
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
  
 
6,770
 
 
 
5,966
 
 
 
5,529
 
 
 
6,770
 
 
 
5,966
 
 
 
5,529
 
Financial liabilities
  
   
 
   
 
   
 
   
 
   
 
   
Bank loans and overdrafts
  
 
(851
 
 
(853
 
 
(1,044
 
 
(851
 
 
(853
 
 
(1,041
Bonds and other loans
  
 
(28,206
 
 
(26,525
 
 
(26,787
 
 
(25,837
 
 
(25,032
 
 
(25,390
Lease liabilities
  
 
(1,849
 
 
(1,919
 
 
(1,967
 
 
(1,849
 
 
(1,919
 
 
(1,967
Derivatives
  
 
(76
 
 
(270
 
 
(464
 
 
(76
 
 
(270
 
 
(464
Other financial liabilities
  
 
(192
 
 
(183
 
 
(123
 
 
(192
 
 
(183
 
 
(123
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
  
 
(31,174
 
 
(29,750
 
 
(30,385
 
 
(28,805
 
 
(28,257
 
 
(28,985
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary of Assets and Liabilities Carried at Fair Value, Classification of Fair Value Calculations by Category
 
  
Level 1
 
  
Level 2
 
 
Level 3
 
 
Level 1
 
  
Level 2
 
 
Level 3
 
 
Level 1
 
  
Level 2
 
 
Level 3
 
€ million
  
As at 30 June 2020
 
 
As at 31 December 2019
 
 
As at 30 June 2019
 
Assets at fair value
  
   
  
   
 
   
 
   
  
   
 
   
 
   
  
   
 
   
Financial assets at fair value through other comprehensive income
  
 
5
 
  
 
4
 
 
 
295
 
 
 
7
 
  
 
4
 
 
 
255
 
 
 
116
 
  
 
4
 
 
 
207
 
Financial assets at fair value through profit or loss:
  
   
  
   
 
   
 
   
  
   
 
   
 
   
  
   
 
   
Derivatives
(a)
  
 
–  
 
  
 
268
 
 
 
–  
 
 
 
–  
 
  
 
208
 
 
 
–  
 
 
 
–  
 
  
 
448
 
 
 
–  
 
Other
  
 
260
 
  
 
–  
 
 
 
283
 
 
 
311
 
  
 
–  
 
 
 
272
 
 
 
155
 
  
 
–  
 
 
 
226
 
Liabilities at fair value
  
   
  
   
 
   
 
   
  
   
 
   
 
   
  
   
 
   
Derivatives
(b)
  
 
–  
 
  
 
(187
 
 
–  
 
 
 
–  
 
  
 
(326
 
 
–  
 
 
 
–  
 
  
 
(530
 
 
–  
 
Contingent Consideration
  
 
–  
 
  
 
–  
 
 
 
(155
 
 
–  
 
  
 
–  
 
 
 
(154
 
 
–  
 
  
 
–  
 
 
 
(156
 
(a)
Includes
103 million (December 2019:
74 million, June 2019:
37 million) derivatives, reported within trade receivables, that hedge trading activities.
(b)
Includes
(111) million (December 2019:
 (56) million, June 2019:
(66) million) derivatives, reported within trade payables, that hedge trading activities.
v3.20.2
Dividends (Tables)
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
Summary of Dividends on Ordinary Capital
The Boards have determined to pay a quarterly interim dividend for Q1 2020 and Q2 2020 at the following rates which are equivalent in value between the two companies at the rate of exchange applied under the terms of the Equalisation Agreement:
 
 
  
Q1 2020
 
  
Q2 2020
 
Per Unilever N.V. ordinary share
  
0.4104
 
  
0.4104
 
Per Unilever PLC ordinary share
  
£
0.3614
 
  
£
0.3698
 
Per Unilever N.V. New York share
  
US$
0.4445
 
  
US$
0.4694
 
Per Unilever PLC American Depositary Receipt
  
US$
 0.4445
 
  
US$
 0.4694
 
Summary of Quarterly Dividend Calendar
The quarterly dividend calendar for the remainder of 2020 will be as follows:
 
 
  
Announcement
Date
  
Ex-Dividend
Date
  
Record Date
  
Payment Date
Q2 2020 Dividend
  
23 July 2020
  
6 August 2020
  
7 August 2020
  
9 September 2020
Q3 2020 Dividend
  
22 October 2020
  
5 November 2020
  
6 November 2020
  
2 December 2020
v3.20.2
Significant Items Within the Income Statement - Summary of Non-underlying Items Related to Gross Profit and Operating Costs (Detail) - EUR (€)
€ in Millions
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Disclosure of non underlying items [Abstract]    
Acquisition and disposal-related credit/(costs) € (27) € (77)
Gain/(loss) on disposal of group companies [1] 6 66
Restructuring costs (391) (454)
Impairment  
One-off items  
Non-underlying items within operating profit before tax (412) (465)
Tax on non-underlying items within operating profit 109 89
Non-underlying items within operating profit after tax (303) (376)
Share of gain on disposal of Spreads business in Portugal JV 3
Net monetary gain arising from hyperinflationary economies 21 29
Non-underlying items not in operating profit but within net profit before tax 21 32
Tax impact of non-underlying items not in operating profit but within net profit:    
Hyperinflation adjustment for Argentina deferred tax (7)  
Non-underlying items not in operating profit but within net profit after tax 14 32
Non-underlying items after tax [2] (289) (344)
Attributable to:    
Non-controlling interests (14) (8)
Shareholders' equity € (275) € (336)
[1] 2019 includes a gain of €60 million relating to disposal of Alsa baking and dessert business.
[2] Non-underlying items after tax is calculated as non-underlying items within operating profit after tax plus non-underlying items not in operating profit but within net profit after tax.
v3.20.2
Significant Items Within the Income Statement - Summary of Non-underlying Items Related to Gross Profit and Operating Costs (Parenthetical) (Detail)
€ in Millions
6 Months Ended
Jun. 30, 2019
EUR (€)
Disclosure of non underlying items [Abstract]  
Gain from sale of Alsa baking and dessert business € 60
v3.20.2
Segment Information Divisions - Summary of Operating Results of Reportable Segments (Detail) - EUR (€)
€ in Millions
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Disclosure of Operating Segments [Line Items]    
Turnover € 25,714 € 26,126
Change (%) (1.60%)  
Impact of acquisitions (%) 1.20%  
Impact of disposals (%) (0.20%)  
Currency-related items (%), of which: (2.50%)  
Exchange rates changes (%) (2.70%)  
Extreme price growth in hyperinflationary markets (%) [1] 0.30%  
Underlying Sales Growth (%) (0.10%)  
Underlying Price Growth (%) [1] 0.20%  
Underlying Volume Growth (%) (0.30%)  
Operating profit € 4,672 4,589
Underlying operating profit € 5,084 € 5,054
Operating margin (%) 18.20% 17.60%
Underlying operating margin (%) 19.80% 19.30%
Beauty & Personal Care [member]    
Disclosure of Operating Segments [Line Items]    
Turnover € 10,610 € 10,721
Change (%) (1.00%)  
Impact of acquisitions (%) 1.30%  
Currency-related items (%), of which: (2.00%)  
Exchange rates changes (%) (2.20%)  
Extreme price growth in hyperinflationary markets (%) [1] 0.30%  
Underlying Sales Growth (%) (0.30%)  
Underlying Price Growth (%) [1] (0.40%)  
Underlying Volume Growth (%) 0.10%  
Operating profit € 2,403 2,322
Underlying operating profit € 2,495 € 2,469
Operating margin (%) 22.60% 21.70%
Underlying operating margin (%) 23.50% 23.00%
Home Care [member]    
Disclosure of Operating Segments [Line Items]    
Turnover € 5,328 € 5,410
Change (%) (1.50%)  
Impact of acquisitions (%) 0.30%  
Currency-related items (%), of which: (4.80%)  
Exchange rates changes (%) (5.10%)  
Extreme price growth in hyperinflationary markets (%) [1] 0.30%  
Underlying Sales Growth (%) 3.20%  
Underlying Price Growth (%) [1] 0.30%  
Underlying Volume Growth (%) 2.90%  
Operating profit € 744 652
Underlying operating profit € 817 € 756
Operating margin (%) 14.00% 12.10%
Underlying operating margin (%) 15.30% 14.00%
Foods & Refreshment [member]    
Disclosure of Operating Segments [Line Items]    
Turnover € 9,776 € 9,995
Change (%) (2.20%)  
Impact of acquisitions (%) 1.70%  
Impact of disposals (%) (0.40%)  
Currency-related items (%), of which: (1.70%)  
Exchange rates changes (%) (2.00%)  
Extreme price growth in hyperinflationary markets (%) [1] 0.30%  
Underlying Sales Growth (%) (1.70%)  
Underlying Price Growth (%) [1] 0.80%  
Underlying Volume Growth (%) (2.50%)  
Operating profit € 1,525 1,615
Underlying operating profit € 1,772 € 1,829
Operating margin (%) 15.60% 16.20%
Underlying operating margin (%) 18.10% 18.30%
[1] Underlying price growth in excess of 26% per year in hyperinflationary economies has been excluded when calculating the price growth in the tables above, and an equal and opposite amount is shown as extreme price growth in hyperinflationary markets.
v3.20.2
Segment Information Divisions - Summary of Operating Results of Reportable Segments (Detail) (Parenthetical)
6 Months Ended
Jun. 30, 2020
Disclosure of operating segments [abstract]  
Hyperinflation percent 0.26
v3.20.2
Segment Information - Geographical Area - Summary of Operating Results by Geographies Areas (Detail) - EUR (€)
€ in Millions
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Additional information by geographies [line items]    
Turnover € 25,714 € 26,126
Change (%) (1.60%)  
Impact of acquisitions (%) 1.20%  
Impact of disposals (%) (0.20%)  
Currency-related items (%), of which: (2.50%)  
Exchange rates changes (%) (2.70%)  
Extreme price growth in hyperinflationary markets (%) [1] 0.30%  
Underlying Sales Growth (%) (0.10%)  
Underlying Price Growth (%) [1] 0.20%  
Underlying Volume Growth (%) (0.30%)  
Operating profit € 4,672 4,589
Underlying operating profit € 5,084 € 5,054
Operating margin (%) 18.20% 17.60%
Underlying operating margin (%) 19.80% 19.30%
Asia/AMET/RUB [member]    
Additional information by geographies [line items]    
Turnover € 11,807 € 12,195
Change (%) (3.20%)  
Impact of acquisitions (%) 1.40%  
Impact of disposals (%) (0.20%)  
Currency-related items (%), of which: (1.70%)  
Exchange rates changes (%) (1.80%)  
Extreme price growth in hyperinflationary markets (%) [1] 0.10%  
Underlying Sales Growth (%) (2.70%)  
Underlying Price Growth (%) [1] 0.20%  
Underlying Volume Growth (%) (2.90%)  
Operating profit € 2,265 2,339
Underlying operating profit € 2,394 € 2,526
Operating margin (%) 19.20% 19.20%
Underlying operating margin (%) 20.30% 20.70%
The Americas [member]    
Additional information by geographies [line items]    
Turnover € 8,227 € 8,141
Change (%) 1.10%  
Impact of acquisitions (%) 1.50%  
Impact of disposals (%) (0.10%)  
Currency-related items (%), of which: (5.10%)  
Exchange rates changes (%) (5.80%)  
Extreme price growth in hyperinflationary markets (%) [1] 0.70%  
Underlying Sales Growth (%) 5.00%  
Underlying Price Growth (%) [1] 0.90%  
Underlying Volume Growth (%) 4.10%  
Operating profit € 1,532 1,270
Underlying operating profit € 1,622 € 1,425
Operating margin (%) 18.60% 15.60%
Underlying operating margin (%) 19.70% 17.50%
Europe [member]    
Additional information by geographies [line items]    
Turnover € 5,680 € 5,790
Change (%) (1.90%)  
Impact of acquisitions (%) 0.50%  
Impact of disposals (%) (0.30%)  
Currency-related items (%), of which: (0.30%)  
Exchange rates changes (%) (0.30%)  
Underlying Sales Growth (%) (1.80%)  
Underlying Price Growth (%) [1] (0.80%)  
Underlying Volume Growth (%) (1.00%)  
Operating profit € 875 980
Underlying operating profit € 1,068 € 1,103
Operating margin (%) 15.40% 16.90%
Underlying operating margin (%) 18.80% 19.10%
[1] Underlying price growth in excess of 26% per year in hyperinflationary economies has been excluded when calculating the price growth in the tables above, and an equal and opposite amount is shown as extreme price growth in hyperinflationary markets.
v3.20.2
Segment Information - Geographical Area - Summary of Operating Results by Geographies Areas (Detail) (Parenthetical)
6 Months Ended
Jun. 30, 2020
Disclosure of operating segments [abstract]  
Hyperinflation percent 0.26
v3.20.2
Taxation - Additional Information (Detail)
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Effective tax rate [abstract]    
Effective tax rate 22.30% 26.80%
v3.20.2
Taxation - Tax Effects of Components of Other Comprehensive Income (Detail) - EUR (€)
€ in Millions
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Before tax    
Gains/(losses) on equity instruments at fair value through other comprehensive income, Before tax € 19 € 16
Gains/(losses) on cash flow hedges, Before tax 71 89
Remeasurements of defined benefit pension plans, Before tax (242) 274
Currency retranslation gains/(losses), Before tax (1,516) 68
Other comprehensive income, Before tax (1,668) 447
Tax (charge)/credit    
Gains/(losses) on equity instruments at fair value through other comprehensive income, Tax (charge)/credit 1  
Gains/(losses) on cash flow hedges, Tax (charge)/credit (28) (6)
Remeasurements of defined benefit pension plans, Tax (charge)/credit 41 (7)
Currency retranslation gains/(losses),Tax (charge)/credit 35 (4)
Other comprehensive income, Tax (charge)/credit 49 (17)
After tax    
Gains/(losses) on equity instruments at fair value through other comprehensive income, After tax 20 16
Gains/(losses) on cash flow hedges, After tax 43 83
Remeasurements of defined benefit pension plans, After tax (201) 267
Currency retranslation gains/(losses), After tax [1] (1,481) 64
Other comprehensive income, After tax € (1,619) € 430
[1] 2020 currency retranslation losses resulted from the weakening of currencies against the euro in our foreign operations, primarily in Brazil, Mexico, India, Korea and Russia.
v3.20.2
Combined Earnings Per Share - Additional Information (Detail)
6 Months Ended
Jun. 30, 2020
Earnings per share [abstract]  
Description on diluted earnings per share and underlying earnings per share calculation In calculating underlying earnings per share, net profit attributable to shareholders’ equity is adjusted to eliminate the post-tax impact of non-underlying items.
v3.20.2
Combined Earnings Per Share - Summary of Computation of Earnings Per Share (Detail) - EUR (€)
€ / shares in Units, € in Millions, shares in Millions
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Combined EPS - Basic    
Net profit attributable to shareholders' equity € 3,284 € 3,006
Average number of combined share units (millions of units) 2,619.0 2,616.5
Combined EPS - basic € 1.25 € 1.15
Combined EPS - Diluted    
Net profit attributable to shareholders' equity € 3,284 € 3,006
Adjusted average number of combined share units 2,627.2 2,625.6
Combined EPS - diluted € 1.25 € 1.14
Underlying EPS    
Net profit attributable to shareholders' equity € 3,284 € 3,006
Post tax impact of non-underlying items attributable to shareholders' equity 275 336
Underlying profit attributable to shareholders' equity € 3,559 € 3,342
Adjusted average number of combined share units (millions of units) 2,627.2 2,625.6
Underlying EPS - diluted € 1.35 € 1.27
v3.20.2
Combined Earnings Per Share - Summary of Movements in Shares (Detail)
shares in Millions
6 Months Ended
Jun. 30, 2020
shares
Earnings per share [abstract]  
Number of shares, beginning balance (net of treasury shares) 2,616.8
Net movement in shares under incentive schemes 4.5
Number of shares, ending balance 2,621.3
v3.20.2
Acquisitions and Disposals - Additional Information (Detail)
€ in Millions
6 Months Ended 12 Months Ended
Apr. 01, 2020
EUR (€)
shares
Mar. 31, 2020
Jun. 30, 2020
EUR (€)
Divisions
shares
Dec. 31, 2019
EUR (€)
Jun. 30, 2019
EUR (€)
Disclosure of Acquisitions and Disposals [Line Items]          
Value of consideration transferred     € 5,526   € 654
Revenue of group if acquisition completed     25,856    
Operating profit of group if acquisition completed     4,711    
Hindustan Unilever Limited [Member]          
Disclosure of Acquisitions and Disposals [Line Items]          
Percentage interest in subsidiary 61.90% 67.20%      
Horlicks Acquisition          
Disclosure of Acquisitions and Disposals [Line Items]          
Value of consideration transferred     5,294    
Revenue of acquiree     142    
Operating profit of acquiree     39    
Goodwill expected to be tax deductible     € 1,300    
Number of shares alloted for every share in acquisition | shares     4.39    
Value of cash transferred     € 449    
Value of equity transferred     € 4,845    
Exchange rate | Divisions     83.05    
Increase (decrease) through net exchange differences, goodwill     € (44)    
Trade and other receivable recognized as of acquisition date € 74        
Contingent liabilities 123        
Contingent assets recognized as of acquisition date € 73        
Acquisition-related costs incurred     29 € 12  
Share issue related cost     € 5    
Number of instruments or interests issued or issuable | shares 184,600,000        
Bangladesh Horlicks Acquisition [Member]          
Disclosure of Acquisitions and Disposals [Line Items]          
Percent of voting interest acquired     82.00%    
v3.20.2
Acquisitions and Disposals - Summary of Net Assets Acquired and Total Payment for Acquisition (Detail) - EUR (€)
€ in Millions
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2019
Disclosure of Detailed Information about Business Combination [Line Items]      
Goodwill € 19,675 € 18,067 € 17,697
Total consideration 5,526   € 654
Horlicks Acquisition [Member]      
Disclosure of Detailed Information about Business Combination [Line Items]      
Intangible assets 3,345    
Other non-current assets 249    
Deferred tax (net) (746)    
Other financial assets 463    
Trade and other receivables 74    
Other current assets 94    
Non-current liabilities (159)    
Current liabilities (122)    
Net assets acquired 3,198    
Total consideration 5,294    
Net cash outflow arising on acquisition:      
Cash consideration (449)    
Less cash and cash equivalents acquired 36    
Total outflow in the consolidated statement of cash flows (413)    
Subsidiaries [member] | Horlicks Acquisition [Member]      
Disclosure of Detailed Information about Business Combination [Line Items]      
Goodwill € 2,096    
v3.20.2
Acquisitions and Disposals - Summary of Impact of the Decrease in Shareholding on the Equity Attributable to Shareholders of the Group (Detail) - Unilever PLC [member]
€ in Millions
6 Months Ended
Jun. 30, 2020
EUR (€)
Disclosure Of Impact Of The Decrease In Shareholding On The Equity Attributable To Shareholders Of The Group [Line Items]  
Net assets acquired before acquisition of GSKCH € 718
Net assets acquired after acquisition of GSKCH 661
Loss recognised in equity due to dilution (57)
Gain arising from proportionate share of GSKCH's net assets acquired 3,001
Net gain arising from the Main Horlicks acquisition recognized in equity € 2,944
v3.20.2
Financial Instruments - Summary of Cash Resources and Other Financial Assets (Detail) - EUR (€)
€ in Millions
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2019
Cash and cash equivalents      
Cash at bank and in hand € 2,672 € 2,457 € 2,157
Short-term deposits with maturity of three months or less 2,176 1,693 1,568
Other cash equivalents 7 35 186
Cash and cash equivalents 4,855 4,185 3,911
Other financial assets      
Financial assets at amortised cost [1] 774 578 239
Financial assets at fair value through other comprehensive income [2] 110
Derivatives that relate to financial liabilities 69 20 411
Other [3] 257 309 153
Other financial assets 1,100 907 913
Current financial assets [4] 5,955 5,092 4,824
Cash and cash equivalents      
Cash at bank and in hand
Short-term deposits with maturity of three months or less
Other cash equivalents
Cash and cash equivalents
Other financial assets      
Financial assets at amortised cost [1] 129 220 260
Financial assets at fair value through other comprehensive income [2] 304 266 217
Derivatives that relate to financial liabilities 96 114
Other [3] 286 274 228
Other financial assets 815 874 705
Non-current financial assets [4] 815 874 705
Cash and cash equivalents      
Cash at bank and in hand 2,672 2,457 2,157
Short-term deposits with maturity of three months or less 2,176 1,693 1,568
Other cash equivalents 7 35 186
Cash and cash equivalents 4,855 4,185 3,911
Other financial assets      
Financial assets at amortised cost [1] 903 798 499
Financial assets at fair value through other comprehensive income [2] 304 266 327
Derivatives that relate to financial liabilities 165 134 411
Other [3] 543 583 381
Other financial assets 1,915 1,781 1,618
Total [4] € 6,770 € 5,966 € 5,529
[1] Current financial assets at amortised cost include short term deposits with banks with maturities longer than three months and loans to joint venture entities. Non-current financial assets at amortised cost include judicial deposit of €94 million (December 2019: €136 million) and investment in bonds of €nil million (December 2019: €56 million).
[2] Included within non-current financial assets at fair value through other comprehensive income are equity investments of €284 million (December 2019: €244 million).
[3] Included within current financial assets at fair value through profit or loss are highly liquid debt mutual funds. Included within non-current financial assets at fair value through profit or loss are assets in a trust to fund benefit obligations in the US and investments in a number of companies and financial institutions in North America, North Asia, South Asia and Europe.
[4] Financial assets exclude trade and other current receivables.
v3.20.2
Financial Instruments - Summary of Cash Resources and Other Financial Assets (Parenthetical) (Detail) - EUR (€)
€ in Millions
Jun. 30, 2020
Dec. 31, 2019
Disclosure of Detailed Information about Financial Instruments [Line Items]    
Equity investments non current at fair value through other comprehensive income € 284 € 244
Non Current Financial Assets At Amortised Cost [Member] | Judicial Deposits [Member]    
Disclosure of Detailed Information about Financial Instruments [Line Items]    
Investments in judicial deposits non current 94 136
Non Current Financial Assets At Amortised Cost [Member] | Bonds [Member]    
Disclosure of Detailed Information about Financial Instruments [Line Items]    
Investment in bonds non current € 56
v3.20.2
Financial Instruments - Summary of Fair Values of Financial Assets and Financial Liabilities (Detail) - EUR (€)
€ in Millions
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2019
Financial assets      
Cash and cash equivalents € 4,855 € 4,185 € 3,911
Financial assets at amortised cost [1] 903 798 499
Financial assets at fair value through other comprehensive income [2] 304 266 327
Fair value [member]      
Financial assets      
Cash and cash equivalents 4,855 4,185 3,911
Financial assets at amortised cost 903 798 499
Financial assets at fair value through other comprehensive income 304 266 327
Financial assets at fair value through profit or loss:      
Financial assets 6,770 5,966 5,529
Financial liabilities      
Bank loans and overdrafts (851) (853) (1,044)
Bonds and other loans (28,206) (26,525) (26,787)
Lease liabilities (1,849) (1,919) (1,967)
Derivatives (76) (270) (464)
Other financial liabilities (192) (183) (123)
Financial liabilities (31,174) (29,750) (30,385)
Fair value [member] | Derivatives [member]      
Financial assets at fair value through profit or loss:      
Financial assets at fair value through profit or loss 165 134 411
Fair value [member] | Other [member]      
Financial assets at fair value through profit or loss:      
Financial assets 543 583 381
Carrying amount [member]      
Financial assets      
Cash and cash equivalents 4,855 4,185 3,911
Financial assets at amortised cost 903 798 499
Financial assets at fair value through other comprehensive income 304 266 327
Financial assets at fair value through profit or loss:      
Financial assets 6,770 5,966 5,529
Financial liabilities      
Bank loans and overdrafts (851) (853) (1,041)
Bonds and other loans (25,837) (25,032) (25,390)
Lease liabilities (1,849) (1,919) (1,967)
Derivatives (76) (270) (464)
Other financial liabilities (192) (183) (123)
Financial liabilities (28,805) (28,257) (28,985)
Carrying amount [member] | Derivatives [member]      
Financial assets at fair value through profit or loss:      
Financial assets at fair value through profit or loss 165 134 411
Carrying amount [member] | Other [member]      
Financial assets at fair value through profit or loss:      
Financial assets € 543 € 583 € 381
[1] Current financial assets at amortised cost include short term deposits with banks with maturities longer than three months and loans to joint venture entities. Non-current financial assets at amortised cost include judicial deposit of €94 million (December 2019: €136 million) and investment in bonds of €nil million (December 2019: €56 million).
[2] Included within non-current financial assets at fair value through other comprehensive income are equity investments of €284 million (December 2019: €244 million).
v3.20.2
Financial Instruments - Summary of Assets and Liabilities Carried at Fair Value, Classification of Fair Value Calculations by Category (Detail) - EUR (€)
€ in Millions
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2019
Disclosure of Detailed Information about Financial Instruments [Line Items]      
Financial assets at fair value through other comprehensive income [1] € 304 € 266 € 327
Financial assets at fair value through profit or loss:      
Other 1,915 1,781 1,618
Fair value [member]      
Disclosure of Detailed Information about Financial Instruments [Line Items]      
Financial assets at fair value through other comprehensive income 304 266 327
Fair value [member] | Level 1 [member]      
Disclosure of Detailed Information about Financial Instruments [Line Items]      
Financial assets at fair value through other comprehensive income 5 7 116
Financial assets at fair value through profit or loss:      
Derivatives [2]
Other 260 311 155
Liabilities at fair value      
Derivatives [3]    
Contingent consideration    
Fair value [member] | Level 2 [member]      
Disclosure of Detailed Information about Financial Instruments [Line Items]      
Financial assets at fair value through other comprehensive income 4 4 4
Financial assets at fair value through profit or loss:      
Derivatives [2] 268 208 448
Other    
Liabilities at fair value      
Derivatives [3] (187) (326) (530)
Contingent consideration    
Fair value [member] | Level 3 [member]      
Disclosure of Detailed Information about Financial Instruments [Line Items]      
Financial assets at fair value through other comprehensive income 295 255 207
Financial assets at fair value through profit or loss:      
Derivatives [2]
Other 283 272 226
Liabilities at fair value      
Derivatives [3]    
Contingent consideration € (155) € (154) € (156)
[1] Included within non-current financial assets at fair value through other comprehensive income are equity investments of €284 million (December 2019: €244 million).
[2] Includes €103 million (December 2019: €74 million, June 2019: €37 million) derivatives, reported within trade receivables, that hedge trading activities.
[3] Includes €(111) million (December 2019: € (56) million, June 2019: €(66) million) derivatives, reported within trade payables, that hedge trading activities.
v3.20.2
Financial Instruments - Summary of Assets and Liabilities Carried at Fair Value, Classification of Fair Value Calculations by Category (Parenthetical) (Detail) - Fair value [member] - EUR (€)
€ in Millions
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2019
Disclosure of Detailed Information about Financial Instruments [Line Items]      
Derivatives assets, reported within trade receivables € 103 € 74 € 37
Derivatives liabilities, reported within trade receivables € (111) € (56) € (66)
v3.20.2
Dividends - Summary of Dividends on Ordinary Capital (Detail)
3 Months Ended
Jun. 30, 2020
€ / shares
Jun. 30, 2020
£ / shares
Jun. 30, 2020
$ / shares
Mar. 31, 2020
€ / shares
Mar. 31, 2020
£ / shares
Mar. 31, 2020
$ / shares
Unilever N.V. [member] | Ordinary Shares [member]            
Disclosure of Dividends [Line Items]            
Dividend per share | € / shares € 0.4104     € 0.4104    
Unilever N.V. [member] | New York Shares [member]            
Disclosure of Dividends [Line Items]            
Dividend per share     $ 0.4694     $ 0.4445
Unilever PLC [member] | Ordinary Shares [member]            
Disclosure of Dividends [Line Items]            
Dividend per share | £ / shares   £ 0.3698     £ 0.3614  
Unilever PLC [member] | American Depositary Receipts [member]            
Disclosure of Dividends [Line Items]            
Dividend per share     $ 0.4694     $ 0.4445
v3.20.2
Dividends - Summary of Quarterly Dividend Calendar (Detail)
6 Months Ended
Jun. 30, 2020
Quarterly Dividend For Q2 2020 [member]  
Disclosure of Dividends [Line Items]  
Announcement Date Jul. 23, 2020
Ex-Dividend Date Aug. 06, 2020
Record Date Aug. 07, 2020
Payment Date Sep. 09, 2020
Quarterly Dividend For Q3 2020 [member]  
Disclosure of Dividends [Line Items]  
Announcement Date Oct. 22, 2020
Ex-Dividend Date Nov. 05, 2020
Record Date Nov. 06, 2020
Payment Date Dec. 02, 2020